{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:24:12Z","timestamp":1785522252870,"version":"3.56.0"},"reference-count":257,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02533-3","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:13:36Z","timestamp":1780017216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasminogen Activation System and Fibroblasts: Impact on Tissue Remodeling, Disease, and Organ Homeostasis"],"prefix":"10.1007","volume":"49","author":[{"given":"Fathimath Muneesa","family":"Moideen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashodhar Prabhakar","family":"Bhandary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"2533_CR1","doi-asserted-by":"publisher","unstructured":"Darby, I. A., B. Laverdet, F. Bont\u00e9, and A. Desmouli\u00e8re. 2014. Fibroblasts and myofibroblasts in wound healing. Clinical, cosmetic and investigational dermatology. 7:301\u2013311. https:\/\/doi.org\/10.2147\/CCID.S50046","DOI":"10.2147\/CCID.S50046"},{"issue":"1","key":"2533_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0765.1997.tb01398.x","volume":"32","author":"RP Phipps","year":"1997","unstructured":"Phipps, R.P., M.A. Borrello, and T.M. Blieden. 1997. Fibroblast heterogeneity in the periodontium and other tissues. J of Periodontal Research 32 (1): 159\u201365. https:\/\/doi.org\/10.1111\/j.1600-0765.1997.tb01398.x.","journal-title":"J of Periodontal Research"},{"issue":"1","key":"2533_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/JCI93555","volume":"128","author":"MD Lynch","year":"2018","unstructured":"Lynch, M.D., and F.M. Watt. 2018. Fibroblast heterogeneity: Implications for human disease. Journal of Clinical Investigation 128 (1): 26\u201335. https:\/\/doi.org\/10.1172\/JCI93555.","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"2533_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tcb.2014.10.001","volume":"25","author":"RR Driskell","year":"2015","unstructured":"Driskell, R. R., and F. M. Watt. 2015. Understanding fibroblast heterogeneity in the skin. Trends in Cell Biology 25(2):92\u201399. https:\/\/doi.org\/10.1016\/j.tcb.2014.10.001","journal-title":"Trends in Cell Biology"},{"issue":"1","key":"2533_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/imr.12990","volume":"302","author":"RN Pradhan","year":"2021","unstructured":"Pradhan, R. N., A. T. Krishnamurty, A. L. Fletcher, S. J. Turley, and S. M\u00fcller. 2021. A bird\u2019s eye view of fibroblast heterogeneity: A pan-disease, pan\u2010cancer perspective. Immunological Reviews 302(1):299\u2013320. https:\/\/doi.org\/10.1111\/imr.12990","journal-title":"Immunological Reviews"},{"key":"2533_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1137659","volume":"14","author":"V Gauthier","year":"2023","unstructured":"Gauthier, V., M. Kyriazi, M. Nefla, V. Pucino, K. Raza, C.D. Buckley, et al. 2023. Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing. Frontiers in Immunology 14: 1137659. https:\/\/doi.org\/10.3389\/fimmu.2023.1137659.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"2533_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17740-1","volume":"11","author":"L Muhl","year":"2020","unstructured":"Muhl, L., G. Genov\u00e9, S. Leptidis, J. Liu, L. He, G. Mocci, et al. 2020. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nature Communications 11 (1): 3953. https:\/\/doi.org\/10.1038\/s41467-020-17740-1.","journal-title":"Nature Communications"},{"key":"2533_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI149538","author":"K Wei","year":"2021","unstructured":"Wei, K., H.N. Nguyen, and M.B. Brenner. 2021. Fibroblast pathology in inflammatory diseases. Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI149538.","journal-title":"Journal of Clinical Investigation"},{"key":"2533_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.737570","volume":"12","author":"S Lovisa","year":"2021","unstructured":"Lovisa, S. 2021. Epithelial-to-mesenchymal transition in fibrosis: Concepts and targeting strategies. Frontiers in Pharmacology 12: 737570. https:\/\/doi.org\/10.3389\/fphar.2021.737570.","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"2533_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148969","volume":"11","author":"K Omori","year":"2016","unstructured":"Omori, K., N. Hattori, T. Senoo, Y. Takayama, T. Masuda, T. Nakashima, et al. 2016. Inhibition of Plasminogen Activator Inhibitor-1 attenuates transforming growth factor-\u03b2-dependent epithelial mesenchymal transition and differentiation of fibroblasts to myofibroblasts. PLoS ONE 11 (2): e0148969. https:\/\/doi.org\/10.1371\/journal.pone.0148969.","journal-title":"PLoS ONE"},{"issue":"5","key":"2533_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/med.21308","volume":"34","author":"AH Mekkawy","year":"2014","unstructured":"Mekkawy, A.H., M.H. Pourgholami, and D.L. Morris. 2014. Involvement of Urokinase-Type Plasminogen Activator System in cancer: An overview. Medicinal Research Reviews 34 (5): 918\u201356. https:\/\/doi.org\/10.1002\/med.21308.","journal-title":"Medicinal Research Reviews"},{"issue":"2","key":"2533_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1006\/excr.2000.5125","volume":"264","author":"C Legrand","year":"2001","unstructured":"Legrand, C., M. Polette, J.M. Tournier, S. De Bentzmann, E. Huet, M. Monteau, et al. 2001. uPA\/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration. Experimental Cell Research 264 (2): 326\u201336. https:\/\/doi.org\/10.1006\/excr.2000.5125.","journal-title":"Experimental Cell Research"},{"issue":"10","key":"2533_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.744","volume":"5","author":"J Wang","year":"2024","unstructured":"Wang, J., K. Li, D. Hao, X. Li, Y. Zhu, H. Yu, et al. 2024. Pulmonary fibrosis: Pathogenesis and therapeutic strategies. MedComm 5 (10): e744. https:\/\/doi.org\/10.1002\/mco2.744.","journal-title":"MedComm"},{"issue":"8","key":"2533_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081838","volume":"13","author":"AG Bharadwaj","year":"2021","unstructured":"Bharadwaj, A.G., R.W. Holloway, V.A. Miller, and D.M. Waisman. 2021. Plasmin and plasminogen system in the tumor microenvironment: Implications for cancer diagnosis, prognosis, and therapy. Cancers 13 (8): 1838. https:\/\/doi.org\/10.3390\/cancers13081838.","journal-title":"Cancers"},{"issue":"1","key":"2533_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32433-y","volume":"8","author":"M Bydoun","year":"2018","unstructured":"Bydoun, M., A. Sterea, I.C.G. Weaver, A.G. Bharadwaj, and D.M. Waisman. 2018. A novel mechanism of plasminogen activation in epithelial and mesenchymal cells. Scientific Reports 8 (1): 14091. https:\/\/doi.org\/10.1038\/s41598-018-32433-y.","journal-title":"Scientific Reports"},{"key":"2533_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1658001","volume":"12","author":"W Li","year":"2025","unstructured":"Li, W., Y. Xie, Z. Chen, D. Cao, and Y. Wang. 2025. Epithelial\u2013mesenchymal transition in pulmonary fibrosis: Molecular mechanisms and emerging therapeutic strategies. Frontiers in Medicine 12: 1658001. https:\/\/doi.org\/10.3389\/fmed.2025.1658001.","journal-title":"Frontiers in Medicine"},{"key":"2533_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkac011","volume":"10","author":"L Liu","year":"2022","unstructured":"Liu, L., Q. Sun, F. Davis, J. Mao, H. Zhao, and D. Ma. 2022. Epithelial\u2013mesenchymal transition in organ fibrosis development: Current understanding and treatment strategies. Burns & Trauma 10: tkac011. https:\/\/doi.org\/10.1093\/burnst\/tkac011.","journal-title":"Burns & Trauma"},{"issue":"4","key":"2533_CR18","doi-asserted-by":"publisher","first-page":"C721","DOI":"10.1152\/ajpcell.00269.2021","volume":"321","author":"SL Gonias","year":"2021","unstructured":"Gonias, S. L. 2021. Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation. American Journal of Physiology-Cell Physiology 321(4):C721\u2013C734. https:\/\/doi.org\/10.1152\/ajpcell.00269.2021","journal-title":"American Journal of Physiology-Cell Physiology"},{"issue":"1","key":"2533_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/bj3020199","volume":"302","author":"J Lamarre","year":"1994","unstructured":"Lamarre, J., J. Vasudevan, and S.L. Gonias. 1994. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor- \u03b2 complex from the cell surface. Biochemical Journal 302 (1): 199\u2013205. https:\/\/doi.org\/10.1042\/bj3020199.","journal-title":"Biochemical Journal"},{"issue":"5","key":"2533_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1242\/jcs.114.5.917","volume":"114","author":"GE Davis","year":"2001","unstructured":"Davis, G. E., K. A. P. Allen, R. Salazar, and S. A. Maxwell. 2001. Matrix metalloproteinase-1 and \u2013\u20099 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. Journal of Cell Science 114(5):917\u2013930. https:\/\/doi.org\/10.1242\/jcs.114.5.917","journal-title":"Journal of Cell Science"},{"key":"2533_CR21","doi-asserted-by":"publisher","unstructured":"Hu, K., C. Wu, W. M. Mars, and Y. Liu. 2007. Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor\u2013related protein 1\u2013mediated integrin signaling. J Clin Invest JCI32301. https:\/\/doi.org\/10.1172\/JCI32301","DOI":"10.1172\/JCI32301"},{"issue":"9","key":"2533_CR22","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/01.ATV.0000030200.59331.3F","volume":"22","author":"UR Pendurthi","year":"2002","unstructured":"Pendurthi, U.R., M. Ngyuen, P. Andrade-Gordon, L.C. Petersen, and L.V.M. Rao. 2002. Plasmin Induces Cyr61 Gene Expression in Fibroblasts Via Protease-Activated Receptor-1 and p44\/42 Mitogen-Activated Protein Kinase\u2013Dependent Signaling Pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 22 (9): 1421\u20136. https:\/\/doi.org\/10.1161\/01.ATV.0000030200.59331.3F.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2533_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2018.00024","volume":"8","author":"N Mahmood","year":"2018","unstructured":"Mahmood, N., C. Mihalcioiu, and S. A. Rabbani. 2018. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications. Frontiers In Oncology 8:24. https:\/\/doi.org\/10.3389\/fonc.2018.00024","journal-title":"Frontiers In Oncology"},{"key":"2533_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/562481","volume":"2011","author":"RP Czekay","year":"2011","unstructured":"Czekay, R.P., C.E. Wilkins-Port, S.P. Higgins, J. Freytag, J.M. Overstreet, R.M. Klein, et al. 2011. PAI-1: An Integrator of Cell Signaling and Migration. International Journal of Cell Biology 2011: 1\u20139. https:\/\/doi.org\/10.1155\/2011\/562481.","journal-title":"International Journal of Cell Biology"},{"issue":"12","key":"2533_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121772","volume":"11","author":"AG Bharadwaj","year":"2021","unstructured":"Bharadwaj, A.G., E. Kempster, and D.M. Waisman. 2021. The ANXA2\/S100A10 Complex\u2014Regulation of the Oncogenic Plasminogen Receptor. Biomolecules 11 (12): 1772. https:\/\/doi.org\/10.3390\/biom11121772.","journal-title":"Biomolecules"},{"issue":"04","key":"2533_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-0033-1334483","volume":"39","author":"L Miles","year":"2013","unstructured":"Miles, L., and R. Parmer. 2013. Plasminogen Receptors: The First Quarter Century. Seminars in Thrombosis and Hemostasis 39 (04): 329\u201337. https:\/\/doi.org\/10.1055\/s-0033-1334483.","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"20","key":"2533_CR27","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.3390\/cancers17203309","volume":"17","author":"A Iftikhar","year":"2025","unstructured":"Iftikhar, A., N. Mahmood, and S. A. Rabbani. 2025. The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. Cancers 17(20):3309. https:\/\/doi.org\/10.3390\/cancers17203309","journal-title":"Cancers"},{"issue":"8","key":"2533_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107521","volume":"300","author":"K Yamamoto","year":"2024","unstructured":"Yamamoto, K., S.D. Scilabra, S. Bonelli, A. Jensen, C. Scavenius, J.J. Enghild, et al. 2024. Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1. Journal of Biological Chemistry 300 (8): 107521. https:\/\/doi.org\/10.1016\/j.jbc.2024.107521.","journal-title":"Journal of Biological Chemistry"},{"issue":"13","key":"2533_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136836","volume":"22","author":"HI Lim","year":"2021","unstructured":"Lim, H.I., and K.A. Hajjar. 2021. Annexin A2 in fibrinolysis, inflammation and fibrosis. IJMS 22 (13): 6836. https:\/\/doi.org\/10.3390\/ijms22136836.","journal-title":"IJMS"},{"issue":"1","key":"2533_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1128\/IAI.72.1.94-105.2004","volume":"72","author":"A Derbise","year":"2004","unstructured":"Derbise, A., Y. P. Song, S. Parikh, V. A. Fischetti, and V. Pancholi. 2004. Role of the C-Terminal Lysine Residues of Streptococcal Surface Enolase in Glu- and Lys-Plasminogen-Binding Activities of Group A Streptococci. Infection And Immunity 72(1):94\u2013105. https:\/\/doi.org\/10.1128\/IAI.72.1.94-105.2004","journal-title":"Infection And Immunity"},{"issue":"1","key":"2533_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02583-3","volume":"24","author":"WC Huang","year":"2023","unstructured":"Huang, W.C., C.F. Chuang, Y.T. Huang, I.C. Chung, M.L. Chen, T.Y. Chuang, et al. 2023. Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis. Respiratory Research 24 (1): 280. https:\/\/doi.org\/10.1186\/s12931-023-02583-3.","journal-title":"Respiratory Research"},{"key":"2533_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/141806","volume":"2012","author":"EF Plow","year":"2012","unstructured":"Plow, E.F., L. Doeuvre, and R. Das. 2012. So many plasminogen receptors: Why? Journal of Biomedicine and Biotechnology 2012: 1\u20136. https:\/\/doi.org\/10.1155\/2012\/141806.","journal-title":"Journal of Biomedicine and Biotechnology"},{"issue":"12","key":"2533_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03230-1","volume":"11","author":"L Ny","year":"2020","unstructured":"Ny, L., R.J. Parmer, Y. Shen, S. Holmberg, N. Baik, A. B\u00e4ckman, et al. 2020. The plasminogen receptor, Plg-RKT, plays a role in inflammation and fibrinolysis during cutaneous wound healing in mice. Cell Death & Disease 11 (12): 1054. https:\/\/doi.org\/10.1038\/s41419-020-03230-1.","journal-title":"Cell Death & Disease"},{"issue":"48","key":"2533_CR34","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1021\/bi981713l","volume":"37","author":"G Kassam","year":"1998","unstructured":"Kassam, G., B.H. Le, K.S. Choi, H.M. Kang, S.L. Fitzpatrick, P. Louie, et al. 1998. The p11 subunit of the Annexin II tetramer plays a key role in the stimulation of t-PA-Dependent plasminogen activation. Biochemistry 37 (48): 16958\u201366. https:\/\/doi.org\/10.1021\/bi981713l.","journal-title":"Biochemistry"},{"issue":"28","key":"2533_CR35","doi-asserted-by":"publisher","first-page":"25577","DOI":"10.1074\/jbc.M301017200","volume":"278","author":"TJ MacLeod","year":"2003","unstructured":"MacLeod, T.J., M. Kwon, N.R. Filipenko, and D.M. Waisman. 2003. Phospholipid-associated Annexin A2-S100A10 heterotetramer and its subunits. Journal of Biological Chemistry 278 (28): 25577\u201384. https:\/\/doi.org\/10.1074\/jbc.M301017200.","journal-title":"Journal of Biological Chemistry"},{"issue":"20","key":"2533_CR36","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1182\/blood-2011-03-344242","volume":"118","author":"S Lighvani","year":"2011","unstructured":"Lighvani, S., N. Baik, J. E. Diggs, S. Khaldoyanidi, R. J. Parmer, and L. A. Miles. 2011. Regulation of macrophage migration by a novel plasminogen receptor Plg-RKT. Blood 118(20):5622\u20135630. https:\/\/doi.org\/10.1182\/blood-2011-03-344242","journal-title":"Blood"},{"issue":"1","key":"2533_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1476-4598-8-88","volume":"8","author":"N Obermajer","year":"2009","unstructured":"Obermajer, N., B. Doljak, and J. Kos. 2009. Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness. Molecular Cancer 8(1):88. https:\/\/doi.org\/10.1186\/1476-4598-8-88","journal-title":"Molecular Cancer"},{"issue":"41","key":"2533_CR38","doi-asserted-by":"publisher","first-page":"25684","DOI":"10.1074\/jbc.271.41.25684","volume":"271","author":"TA Hembrough","year":"1996","unstructured":"Hembrough, T. A., L. Li, and S. L. Gonias. 1996. Cell-surface Cytokeratin 8 Is the Major Plasminogen Receptor on Breast Cancer Cells and Is Required for the Accelerated Activation of Cell-associated Plasminogen by Tissue-type Plasminogen Activator. Journal of Biological Chemistry 271(41):25684\u201325691. https:\/\/doi.org\/10.1074\/jbc.271.41.25684","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"2533_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020211","volume":"12","author":"M Das","year":"2022","unstructured":"Das, M., S.S. Ithychanda, and E.F. Plow. 2022. Histone 2B facilitates plasminogen-enhanced endothelial migration through protease-activated receptor 1 (PAR1) and protease-activated receptor 2 (PAR2). Biomolecules 12 (2): 211. https:\/\/doi.org\/10.3390\/biom12020211.","journal-title":"Biomolecules"},{"issue":"8","key":"2533_CR40","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/jth.14157","volume":"16","author":"T Urano","year":"2018","unstructured":"Urano, T., F.J. Castellino, and Y. Suzuki. 2018. Regulation of plasminogen activation on cell surfaces and fibrin. Journal of thrombosis and haemostasis\u202f: JTH 16 (8): 1487\u201397. https:\/\/doi.org\/10.1111\/jth.14157.","journal-title":"Journal of thrombosis and haemostasis : JTH"},{"issue":"4","key":"2533_CR41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ng1297-439","volume":"17","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet, P., L. Moons, R. Lijnen, M. Baes, V. Lema\u00eetre, P. Tipping, et al. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nature Genetics 17 (4): 439\u201344. https:\/\/doi.org\/10.1038\/ng1297-439.","journal-title":"Nature Genetics"},{"issue":"1","key":"2533_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrm2821","volume":"11","author":"HW Smith","year":"2010","unstructured":"Smith, H.W., and C.J. Marshall. 2010. Regulation of cell signalling by uPAR. Nature Reviews. Molecular Cell Biology 11 (1): 23\u201336. https:\/\/doi.org\/10.1038\/nrm2821.","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"2533_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.33.Suppl_14.1","volume":"14","author":"JF Davidson","year":"1980","unstructured":"Davidson, J.F., and I.D. Walker. 1980. Biological role of fibrinolysis. Journal of clinical pathology Supplement (Royal College of Pathologists) 14: 1\u20134.","journal-title":"Journal of clinical pathology Supplement (Royal College of Pathologists)"},{"issue":"12","key":"2533_CR44","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1182\/blood.V78.12.3114.3114","volume":"78","author":"D Collen","year":"1991","unstructured":"Collen, D., and H. R. Lijnen. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78(12):3114\u20133124. PubMed PMID: 1742478.","journal-title":"Blood"},{"issue":"10","key":"2533_CR45","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1073\/pnas.80.10.2956","volume":"80","author":"DJ Loskutoff","year":"1983","unstructured":"Loskutoff, D.J., J.A. van Mourik, L.A. Erickson, and D. Lawrence. 1983. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 80 (10): 2956\u201360. https:\/\/doi.org\/10.1073\/pnas.80.10.2956.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"2533_CR46","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1160\/TH08-07-0427","volume":"100","author":"RD Balsara","year":"2008","unstructured":"Balsara, R.D., and V.A. Ploplis. 2008. Plasminogen activator inhibitor-1: The double-edged sword in apoptosis. Thrombosis and Haemostasis 100 (6): 1029\u201336.","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"2533_CR47","first-page":"1041","volume":"100","author":"UA Lademann","year":"2008","unstructured":"Lademann, U.A., and M.U. R\u00f8mer. 2008. Regulation of programmed cell death by plasminogen activator inhibitor type 1 (PAI-1). Thrombosis and Haemostasis 100 (6): 1041\u20136.","journal-title":"Thrombosis and Haemostasis"},{"issue":"20","key":"2533_CR48","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1182\/blood-2013-05-427708","volume":"122","author":"F Samad","year":"2013","unstructured":"Samad, F., and W. Ruf. 2013. Inflammation, obesity, and thrombosis. Blood 122 (20): 3415\u201322. https:\/\/doi.org\/10.1182\/blood-2013-05-427708.","journal-title":"Blood"},{"key":"2533_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080341","author":"R Samarakoon","year":"2019","unstructured":"Samarakoon, R., S.P. Higgins, C.E. Higgins, and P.J. Higgins. 2019. The TGF-\u03b21\/p53\/PAI-1 signaling axis in vascular senescence: Role of Caveolin-1. Biomolecules. https:\/\/doi.org\/10.3390\/biom9080341.","journal-title":"Biomolecules"},{"issue":"8","key":"2533_CR50","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","volume":"37","author":"DE Vaughan","year":"2017","unstructured":"Vaughan, D.E., R. Rai, S.S. Khan, M. Eren, and A.K. Ghosh. 2017. Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. ATVB 37 (8): 1446\u201352. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309451.","journal-title":"ATVB"},{"issue":"1","key":"2533_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2025.100892","volume":"49","author":"A Khoddam","year":"2026","unstructured":"Khoddam, A., T. Miyata, and D. Vaughan. 2026. PAI-1 is a common driver of aging and diverse diseases. Biomedical Journal 49 (1): 100892. https:\/\/doi.org\/10.1016\/j.bj.2025.100892.","journal-title":"Biomedical Journal"},{"issue":"2","key":"2533_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jcp.22783","volume":"227","author":"AK Ghosh","year":"2012","unstructured":"Ghosh, A.K., and D.E. Vaughan. 2012. PAI-1 in tissue fibrosis. Journal of Cellular Physiology 227 (2): 493\u2013507. https:\/\/doi.org\/10.1002\/jcp.22783.","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"2533_CR53","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/ATVBAHA.119.313775","volume":"40","author":"HB Khoukaz","year":"2020","unstructured":"Khoukaz, H.B., Y. Ji, D.J. Braet, M. Vadali, A.A. Abdelhamid, C.D. Emal, et al. 2020. Drug targeting of Plasminogen Activator Inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 40 (6): 1479\u201390. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313775.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"2533_CR54","doi-asserted-by":"publisher","first-page":"C217","DOI":"10.1152\/ajpcell.00555","volume":"289","author":"TJ Koh","year":"2005","unstructured":"Koh, T. J., S. C. Bryer, A. M. Pucci, and T. H. Sisson. 2005. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. American journal of physiology Cell physiology 289(1):C217\u2013C223. https:\/\/doi.org\/10.1152\/ajpcell.00555. .2004 PubMed PMID: 15716324.","journal-title":"American journal of physiology Cell physiology"},{"key":"2533_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.biopha.2018.05.119","volume":"105","author":"S Li","year":"2018","unstructured":"Li, S., X. Wei, J. He, X. Tian, S. Yuan, and L. Sun. 2018. Plasminogen activator inhibitor-1 in cancer research. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie 105:83\u201394. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.119 . PubMed PMID: 29852393.","journal-title":"Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie"},{"issue":"14","key":"2533_CR56","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2741\/3361","volume":"Volume","author":"LJ Ma","year":"2009","unstructured":"Ma, L. J. 2009. PAI-1 and kidney fibrosis. Frontiers In Bioscience : A Journal And Virtual Library Volume(14):2028. https:\/\/doi.org\/10.2741\/3361","journal-title":"Frontiers In Bioscience : A Journal And Virtual Library"},{"issue":"15","key":"2533_CR57","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","volume":"75","author":"VR Placencio","year":"2015","unstructured":"Placencio, V. R., and Y. A. DeClerck. 2015. Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing. Cancer research 75(15):2969\u20132974. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0876 . PubMed PMID: 26180080.","journal-title":"Cancer research"},{"key":"2533_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-021-00153-z","author":"RN Gomes","year":"2021","unstructured":"Gomes, R.N., F. Manuel, and D.S. Nascimento. 2021. The bright side of fi broblasts: Molecular signature and regenerative cues in major organs. npj Regenerative Medicine. https:\/\/doi.org\/10.1038\/s41536-021-00153-z.","journal-title":"npj Regenerative Medicine"},{"issue":"1","key":"2533_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1465-9921-12-48","volume":"12","author":"M L\u00f6fdahl","year":"2011","unstructured":"L\u00f6fdahl, M., R. Kaarteenaho, E. Lappi-Blanco, G. Tornling, and M. C. Sk\u00f6ld. 2011. Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD. Respiratory research 12(1):48. https:\/\/doi.org\/10.1186\/1465-9921-12-48 . PubMed PMID: 21496259.","journal-title":"Respiratory research"},{"key":"2533_CR60","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00876-2020","author":"MS Eapen","year":"2021","unstructured":"Eapen, M.S., W. Lu, T.L. Hackett, G.K. Singhera, M.Q. Mahmood, A. Hardikar, et al. 2021. Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: Potential role of epithelial-mesenchymal transition. ERJ Open Research. https:\/\/doi.org\/10.1183\/23120541.00876-2020.","journal-title":"ERJ Open Research"},{"issue":"6","key":"2533_CR61","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/resp.13021","volume":"22","author":"MS Eapen","year":"2017","unstructured":"Eapen, M. S., K. McAlinden, D. Tan, S. Weston, C. Ward, and H. K. Muller et al. 2017. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology (Carlton Vic) 22(6):1125\u20131132. https:\/\/doi.org\/10.1111\/resp.13021 . PubMed PMID: 28326668.","journal-title":"Respirology (Carlton Vic)"},{"issue":"1","key":"2533_CR62","doi-asserted-by":"publisher","first-page":"13392","DOI":"10.1038\/s41598-017","volume":"7","author":"MS Eapen","year":"2017","unstructured":"Eapen, M. S., P. M. Hansbro, K. McAlinden, R. Y. Kim, C. Ward, and T. L. Hackett et al. 2017. Abnormal M1\/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Scientific reports 7(1):13392. https:\/\/doi.org\/10.1038\/s41598-017-. 13888-x PubMed PMID: 29042607.","journal-title":"Scientific reports"},{"key":"2533_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040342","author":"JT Ito","year":"2019","unstructured":"Ito, J.T., J.D. Louren\u00e7o, R.F. Righetti, I.F.L.C. Tib\u00e9rio, C.M. Prado, and F.D.T.Q.S. Lopes. 2019. Extracellular matrix component remodeling in respiratory diseases: What has been found in clinical and experimental studies? Cells. https:\/\/doi.org\/10.3390\/cells8040342.","journal-title":"Cells"},{"issue":"1","key":"2533_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajpath.2014.08.027","volume":"185","author":"AS Marudamuthu","year":"2015","unstructured":"Marudamuthu, A. S., Y. P. Bhandary, S. K. Shetty, J. Fu, V. Sathish, and Y. Prakash et al. 2015. Role of the Urokinase-Fibrinolytic System in Epithelial\u2013Mesenchymal Transition during Lung Injury. The American Journal of Pathology 185(1):55\u201368. https:\/\/doi.org\/10.1016\/j.ajpath.2014.08.027","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"2533_CR65","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S0002-9440(10)63196-3","volume":"164","author":"N Hattori","year":"2004","unstructured":"Hattori, N., S. Mizuno, Y. Yoshida, K. Chin, M. Mishima, T.H. Sisson, et al. 2004. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. The American Journal of Pathology 164 (3): 1091\u20138. https:\/\/doi.org\/10.1016\/S0002-9440(10)63196-3.","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"2533_CR66","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1165\/rcmb.2006-0006OC","volume":"35","author":"H Matsuoka","year":"2006","unstructured":"Matsuoka, H., T. H. Sisson, T. Nishiuma, and R. H. Simon. 2006. Plasminogen-Mediated Activation and Release of Hepatocyte Growth Factor from Extracellular Matrix. American Journal of Respiratory Cell and Molecular Biology 35(6):705\u2013713. https:\/\/doi.org\/10.1165\/rcmb.2006-0006OC","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"2533_CR67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.biocel.2018.02.016","volume":"97","author":"M Schuliga","year":"2018","unstructured":"Schuliga, M., C. Grainge, G. Westall, and D. Knight. 2018. The fibrogenic actions of the coagulant and plasminogen activation systems in pulmonary fibrosis. The International Journal of Biochemistry & Cell Biology 97:108\u2013117. https:\/\/doi.org\/10.1016\/j.biocel.2018.02.016","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"9","key":"2533_CR68","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2174\/138945007781662319","volume":"8","author":"T Sisson","year":"2007","unstructured":"Sisson, T., and R. Simon. 2007. The Plasminogen Activation System in Lung Disease. CDT 8(9):1016\u20131029. https:\/\/doi.org\/10.2174\/138945007781662319","journal-title":"CDT"},{"issue":"3","key":"2533_CR69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2141.2012.09074.x","volume":"157","author":"T Iwaki","year":"2012","unstructured":"Iwaki, T., T. Urano, and K. Umemura. 2012. PAI-1, progress in understanding the clinical problem and its aetiology. British Journal of Haematology 157 (3): 291\u20138. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09074.x.","journal-title":"British Journal of Haematology"},{"issue":"2","key":"2533_CR70","doi-asserted-by":"publisher","first-page":"e0148969","DOI":"10.1371\/journal.pone.0148969","volume":"11","author":"K Omori","year":"2016","unstructured":"Omori, K., N. Hattori, T. Senoo, Y. Takayama, T. Masuda, T. Nakashima, et al. 2016. Inhibition of plasminogen activator inhibitor-1 attenuates transforming growth factor-\u03b2-dependent epithelial mesenchymal transition and differentiation of fibroblasts to myofibroblasts. PLoS One 11 (2): e0148969\u2013e0148969. https:\/\/doi.org\/10.1371\/journal.pone.0148969.","journal-title":"PLoS One"},{"issue":"11","key":"2533_CR71","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1172\/JCI10531","volume":"106","author":"N Hattori","year":"2000","unstructured":"Hattori, N., J.L. Degen, T.H. Sisson, H. Liu, B.B. Moore, R.G. Pandrangi, et al. 2000. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. The Journal of Clinical Investigation 106 (11): 1341\u201350. https:\/\/doi.org\/10.1172\/JCI10531.","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"2533_CR72","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/art.39443","volume":"68","author":"R Lemaire","year":"2016","unstructured":"Lemaire, R., T. Burwell, H. Sun, T. Delaney, J. Bakken, L. Cheng, et al. 2016. Resolution of skin fibrosis by neutralization of the antifibrinolytic function of plasminogen activator inhibitor 1. Arthritis & Rheumatology 68 (2): 473\u201383. https:\/\/doi.org\/10.1002\/art.39443.","journal-title":"Arthritis & Rheumatology"},{"issue":"Pt 10","key":"2533_CR73","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1242\/jcs.020149","volume":"121","author":"D Vial","year":"2008","unstructured":"Vial, D., and P.J. McKeown-Longo. 2008. PAI1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the alphavbeta5 and alpha5beta1 integrins. Journal of Cell Science 121 (Pt 10): 1661\u201370. https:\/\/doi.org\/10.1242\/jcs.020149.","journal-title":"Journal of Cell Science"},{"issue":"5","key":"2533_CR74","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1083\/jcb.200208117","volume":"160","author":"RP Czekay","year":"2003","unstructured":"Czekay, R.P., K. Aertgeerts, S.A. Curriden, and D.J. Loskutoff. 2003. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. The Journal of cell biology 160 (5): 781\u201391. https:\/\/doi.org\/10.1083\/jcb.200208117.","journal-title":"The Journal of cell biology"},{"issue":"5","key":"2533_CR75","doi-asserted-by":"publisher","first-page":"L772","DOI":"10.1152\/ajplung.00553.2016","volume":"312","author":"M Schuliga","year":"2017","unstructured":"Schuliga, M., J. Jaffar, A. Berhan, S. Langenbach, T. Harris, D. Waters, et al. 2017. Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity. American Journal of Physiology-Lung Cellular and Molecular Physiology 312 (5): L772-82. https:\/\/doi.org\/10.1152\/ajplung.00553.2016.","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"7","key":"2533_CR76","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/CS20180687","volume":"133","author":"Y Lei","year":"2019","unstructured":"Lei, Y., K. Wang, X. Li, Y. Li, X. Feng, J. Zhou, et al. 2019. Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice. Clinical Science 133 (7): 789\u2013804. https:\/\/doi.org\/10.1042\/CS20180687.","journal-title":"Clinical Science"},{"issue":"9","key":"2533_CR77","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1084\/jem.20160652","volume":"214","author":"M Luo","year":"2017","unstructured":"Luo, M., E.C. Flood, D. Almeida, L. Yan, D.A. Berlin, P.M. Heerdt, et al. 2017. Annexin A2 supports pulmonary microvascular integrity by linking vascular endothelial cadherin and protein tyrosine phosphatases. Journal of Experimental Medicine 214 (9): 2535\u201345. https:\/\/doi.org\/10.1084\/jem.20160652.","journal-title":"Journal of Experimental Medicine"},{"key":"2533_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1564176","volume":"12","author":"C Zheng","year":"2025","unstructured":"Zheng, C., L. Zhang, Y. Sun, Y. Ma, and Y. Zhang. 2025. Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis. Frontiers in Molecular Biosciences 12: 1564176. https:\/\/doi.org\/10.3389\/fmolb.2025.1564176.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"2533_CR79","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ajpath.2013.03.022","volume":"183","author":"YP Bhandary","year":"2013","unstructured":"Bhandary, Y.P., S.K. Shetty, A.S. Marudamuthu, H.L. Ji, P.F. Neuenschwander, V. Boggaram, et al. 2013. Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1. The American Journal of Pathology 183 (1): 131\u201343. https:\/\/doi.org\/10.1016\/j.ajpath.2013.03.022.","journal-title":"The American Journal of Pathology"},{"issue":"2","key":"2533_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2689-999X\/2019\/2.1149","volume":"3","author":"C Hill","year":"2019","unstructured":"Hill, C., M. G. Jones, D. E. Davies, and Y. Wang. 2019. Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial\/fibroblastic cross-talk. J Lung Health Dis 3(2):31\u201335. PubMed PMID: 31032489; PubMed Central PMCID: PMC6485666.","journal-title":"J Lung Health Dis"},{"issue":"5","key":"2533_CR81","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41418-018-0175-7","volume":"26","author":"L Yao","year":"2019","unstructured":"Yao, L., F. Conforti, C. Hill, J. Bell, L. Drawater, J. Li, et al. 2019. Paracrine signalling during ZEB1-mediated epithelial\u2013mesenchymal transition augments local myofibroblast differentiation in lung fibrosis. Cell Death & Differentiation 26 (5): 943\u201357. https:\/\/doi.org\/10.1038\/s41418-018-0175-7.","journal-title":"Cell Death & Differentiation"},{"key":"2533_CR82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.exger.2014.11.018","volume":"61","author":"WT Huang","year":"2015","unstructured":"Huang, W.T., H. Akhter, C. Jiang, M. MacEwen, Q. Ding, V. Antony, et al. 2015. Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis. Experimental Gerontology 61: 62\u201375. https:\/\/doi.org\/10.1016\/j.exger.2014.11.018.","journal-title":"Experimental Gerontology"},{"issue":"1","key":"2533_CR83","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2381803","volume":"13","author":"J Li","year":"2024","unstructured":"Li, J., C. Zhou, X. Gao, T. Tan, M. Zhang, Y. Li, et al. 2024. S100A10 promotes cancer metastasis via recruitment of MDSCs within the lungs. OncoImmunology 13 (1): 2381803. https:\/\/doi.org\/10.1080\/2162402X.2024.2381803.","journal-title":"OncoImmunology"},{"issue":"12","key":"2533_CR84","doi-asserted-by":"publisher","first-page":"4122","DOI":"10.3390\/ijms19124122","volume":"19","author":"TM Noye","year":"2018","unstructured":"Noye, T. M., N. A. Lokman, M. K. Oehler, and C. Ricciardelli. 2018. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer. IJMS 19(12):4122. https:\/\/doi.org\/10.3390\/ijms19124122","journal-title":"IJMS"},{"issue":"8982","key":"2533_CR85","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/s0140-6736(95)91744-6","volume":"346","author":"NA Hern\u00e1ndez-Rodr\u00edguez","year":"1995","unstructured":"Hern\u00e1ndez-Rodr\u00edguez, N.A., A.D. Cambrey, N.K. Harrison, R.C. Chambers, A.J. Gray, A.M. Southcott, et al. 1995. Role of thrombin in pulmonary fibrosis. Lancet (London, England) 346 (8982): 1071\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(95)91744-6.","journal-title":"Lancet (London, England)"},{"issue":"5","key":"2533_CR86","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S0002-9440(10)62354-1","volume":"166","author":"DCJ Howell","year":"2005","unstructured":"Howell, D.C.J., R.H. Johns, J.A. Lasky, B. Shan, C.J. Scotton, G.J. Laurent, et al. 2005. Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. The American Journal of Pathology 166 (5): 1353\u201365. https:\/\/doi.org\/10.1016\/S0002-9440(10)62354-1.","journal-title":"The American Journal of Pathology"},{"issue":"2","key":"2533_CR87","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/thoraxjnl-2013-204367","volume":"69","author":"RJ Jos\u00e9","year":"2014","unstructured":"Jos\u00e9, R.J., A.E. Williams, and R.C. Chambers. 2014. Proteinase-activated receptors in fibroproliferative lung disease. Thorax 69 (2): 190\u20132. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204367.","journal-title":"Thorax"},{"key":"2533_CR88","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.exer.2012.03.018","volume":"99","author":"SE Wilson","year":"2012","unstructured":"Wilson, S.E. 2012. Corneal myofibroblast biology and pathobiology: Generation, persistence, and transparency. Experimental Eye Research 99: 78\u201388. https:\/\/doi.org\/10.1016\/j.exer.2012.03.018.","journal-title":"Experimental Eye Research"},{"issue":"September","key":"2533_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108229","volume":"200","author":"K Fukuda","year":"2020","unstructured":"Fukuda, K. 2020. Corneal fibroblasts\u202f: Function and markers. Experimental Eye Research 200 (September): 108229. https:\/\/doi.org\/10.1016\/j.exer.2020.108229.","journal-title":"Experimental Eye Research"},{"issue":"Suppl 1","key":"2533_CR90","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1097\/ICO.0b013e318269ccd0","volume":"31","author":"T Sakimoto","year":"2012","unstructured":"Sakimoto, T., and M. Sawa. 2012. Metalloproteinases in corneal diseases: Degradation and processing. Cornea 31 (Suppl 1): S50-6. https:\/\/doi.org\/10.1097\/ICO.0b013e318269ccd0.","journal-title":"Cornea"},{"issue":"7","key":"2533_CR91","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1091\/mbc.e06-10-0912","volume":"18","author":"AM Bernstein","year":"2007","unstructured":"Bernstein, A.M., S.S. Twining, D.J. Warejcka, E. Tall, and S.K. Masur. 2007. Urokinase receptor cleavage: A crucial step in fibroblast-to-myofibroblast differentiation. Molecular Biology of the Cell 18 (7): 2716\u201327. https:\/\/doi.org\/10.1091\/mbc.e06-10-0912.","journal-title":"Molecular Biology of the Cell"},{"issue":"3","key":"2533_CR92","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1167\/iovs.16-20685","volume":"58","author":"K Sugioka","year":"2017","unstructured":"Sugioka, K., A. Kodama-Takahashi, K. Yoshida, K. Aomatsu, K. Okada, T. Nishida, et al. 2017. Extracellular collagen promotes Interleukin-1\u03b2-induced urokinase-type plasminogen activator production by human corneal fibroblasts. Investigative Opthalmology & Visual Science 58 (3): 1487\u201398. https:\/\/doi.org\/10.1167\/iovs.16-20685.","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"12","key":"2533_CR93","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1167\/iovs.18-24925","volume":"59","author":"K Sugioka","year":"2018","unstructured":"Sugioka, K., A. Kodama-Takahshi, T. Sato, K. Okada, J. Murakami, A.M. Park, et al. 2018. Plasminogen-dependent collagenolytic properties of Staphylococcus aureus in collagen gel cultures of human corneal fibroblasts. Investigative Ophthalmology & Visual Science 59 (12): 5098\u2013107. https:\/\/doi.org\/10.1167\/iovs.18-24925.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"2533_CR94","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40662-024-00387-0","volume":"11","author":"L Jin","year":"2024","unstructured":"Jin, L., L. Zhang, C. Yan, M. Liu, D. C. Dean, and Y. Liu. 2024. Corneal injury repair and the potential involvement of ZEB1. Eye and Vis 11(1):20. https:\/\/doi.org\/10.1186\/s40662-024-00387-0","journal-title":"Eye and Vis"},{"key":"2533_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109559","volume":"233","author":"K Sugioka","year":"2023","unstructured":"Sugioka, K., T. Nishida, A. Kodama-Takahashi, J. Murakami, M. Fukuda, O. Matsuo, et al. 2023. Urokinase-type plasminogen activator promotes corneal epithelial migration and nerve regeneration. Experimental Eye Research 233: 109559. https:\/\/doi.org\/10.1016\/j.exer.2023.109559.","journal-title":"Experimental Eye Research"},{"issue":"5","key":"2533_CR96","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.exer.2011.07.008","volume":"93","author":"DJ Warejcka","year":"2011","unstructured":"Warejcka, D. J., M. Narayan, and S. S. Twining. 2011. Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts. Experimental Eye Research 93(5):618\u2013627. https:\/\/doi.org\/10.1016\/j.exer.2011.07.008","journal-title":"Experimental Eye Research"},{"issue":"2","key":"2533_CR97","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jcp.10126","volume":"192","author":"S Monea","year":"2002","unstructured":"Monea, S., K. Lehti, J. Keski-Oja, and P. Mignatti. 2002. Plasmin activates pro\u2010matrix metalloproteinase\u20102 with a membrane\u2010type 1 matrix metalloproteinase\u2010dependent mechanism. Journal Cellular Physiology 192(2):160\u2013170. https:\/\/doi.org\/10.1002\/jcp.10126","journal-title":"Journal Cellular Physiology"},{"issue":"9","key":"2533_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/biology12091263","volume":"12","author":"K Jadczyk-Sorek","year":"2023","unstructured":"Jadczyk-Sorek, K., W. Garczorz, B. Buba\u0142a-Stachowicz, T. Francuz, and E. Mrukwa-Kominek. 2023. Matrix metalloproteinases and the pathogenesis of recurrent corneal erosions and epithelial basement membrane dystrophy. Biology 12 (9): 1263. https:\/\/doi.org\/10.3390\/biology12091263.","journal-title":"Biology"},{"issue":"8","key":"2533_CR99","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1167\/iovs.12-10042","volume":"53","author":"L Wang","year":"2012","unstructured":"Wang, L., C. M. Ly, C. Y. Ko, E. E. Meyers, D. A. Lawrence, and A. M. Bernstein. 2012. uPA Binding to PAI-1 Induces Corneal Myofibroblast Differentiation on Vitronectin. Invest Ophthalmol Vis Sci 53(8):4765. https:\/\/doi.org\/10.1167\/iovs.12-10042","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2533_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52675-x","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo, M., D. Almeida, V. Dallacasagrande, N. Hedhli, M. Gupta, D.J. D\u2019Amico, et al. 2024. Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice. Nature Communications 15 (1): 8757. https:\/\/doi.org\/10.1038\/s41467-024-52675-x.","journal-title":"Nature Communications"},{"issue":"51","key":"2533_CR101","doi-asserted-by":"publisher","first-page":"35193","DOI":"10.1074\/jbc.M114.586461","volume":"289","author":"Y Mori","year":"2014","unstructured":"Mori, Y., K. Akita, S. Tanida, A. Ishida, M. Toda, M. Inoue, et al. 2014. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-\u03baB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells. The Journal of Biological Chemistry 289 (51): 35193\u2013204. https:\/\/doi.org\/10.1074\/jbc.M114.586461.","journal-title":"The Journal of Biological Chemistry"},{"issue":"13","key":"2533_CR102","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1167\/iovs.19-27736","volume":"60","author":"T Sato","year":"2019","unstructured":"Sato, T., K. Sugioka, A. Kodama-Takahashi, J. Murakami, A. Saito, H. Mishima, et al. 2019. Stimulation of phagocytic activity in cultured human corneal fibroblasts by plasminogen. Investigative Ophthalmology & Visual Science 60 (13): 4205\u201314. https:\/\/doi.org\/10.1167\/iovs.19-27736.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"34","key":"2533_CR103","doi-asserted-by":"publisher","first-page":"31796","DOI":"10.1074\/jbc.M302408200","volume":"278","author":"C Ngamkitidechakul","year":"2003","unstructured":"Ngamkitidechakul, C., D.J. Warejcka, J.M. Burke, W.J. O\u2019Brien, and S.S. Twining. 2003. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. The Journal of Biological Chemistry 278 (34): 31796\u2013806. https:\/\/doi.org\/10.1074\/jbc.M302408200.","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"2533_CR104","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.exer.2011.07.008","volume":"93","author":"DJ Warejcka","year":"2011","unstructured":"Warejcka, D.J., M. Narayan, and S.S. Twining. 2011. Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts. Experimental Eye Research 93 (5): 618\u201327. https:\/\/doi.org\/10.1016\/j.exer.2011.07.008.","journal-title":"Experimental Eye Research"},{"issue":"3","key":"2533_CR105","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/(SICI)1097-4652(199606)167:3<500::AID-JCP14>3.0.CO;2-7","volume":"167","author":"Y Ando","year":"1996","unstructured":"Ando, Y., and P.J. Jensen. 1996. Protein kinase c mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. Journal of Cellular Physiology 167 (3): 500\u201311.","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"2533_CR106","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0092-8674(00)81390-2","volume":"87","author":"TH Bugge","year":"1996","unstructured":"Bugge, T.H., K.W. Kombrinck, M.J. Flick, C.C. Daugherty, M.J. Danton, and J.L. Degen. 1996. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 87 (4): 709\u201319. https:\/\/doi.org\/10.1016\/s0092-8674(00)81390-2.","journal-title":"Cell"},{"issue":"3","key":"2533_CR107","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nm0396-287","volume":"2","author":"J Romer","year":"1996","unstructured":"Romer, J., T.H. Bugge, C. Pyke, L.R. Lund, M.J. Flick, J.L. Degen, et al. 1996. Impaired wound healing in mice with a disrupted plasminogen gene. Nature Medicine 2 (3): 287\u201392. https:\/\/doi.org\/10.1038\/nm0396-287.","journal-title":"Nature Medicine"},{"issue":"12","key":"2533_CR108","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1038\/sj.emboj.7601173","volume":"25","author":"LR Lund","year":"2006","unstructured":"Lund, L.R., K.A. Green, A.A. Stoop, M. Ploug, K. Almholt, J. Lilla, et al. 2006. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. The EMBO Journal 25 (12): 2686\u201397. https:\/\/doi.org\/10.1038\/sj.emboj.7601173.","journal-title":"The EMBO Journal"},{"issue":"17","key":"2533_CR109","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1093\/emboj\/18.17.4645","volume":"18","author":"LR Lund","year":"1999","unstructured":"Lund, L.R., J. Romer, T.H. Bugge, B.S. Nielsen, T.L. Frandsen, J.L. Degen, et al. 1999. Functional overlap between two classes of matrix-degrading proteases in wound healing. The EMBO Journal 18 (17): 4645\u201356. https:\/\/doi.org\/10.1093\/emboj\/18.17.4645.","journal-title":"The EMBO Journal"},{"issue":"4","key":"2533_CR110","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3892\/mmr.2020.11358","volume":"22","author":"H Niwa","year":"2020","unstructured":"Niwa, H., Y. Kanno, E. Shu, and M. Seishima. 2020. Decrease in matrix metalloproteinase\u20113 activity in systemic sclerosis fibroblasts causes \u03b12\u2011antiplasmin and extracellular matrix deposition, and contributes to fibrosis development. Molecular Medicine Reports 22 (4): 3001\u20137. https:\/\/doi.org\/10.3892\/mmr.2020.11358.","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"2533_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55176-w","volume":"9","author":"A Jeffers","year":"2019","unstructured":"Jeffers, A., W. Qin, S. Owens, K.B. Koenig, S. Komatsu, F.J. Giles, et al. 2019. Glycogen Synthase Kinase-3\u03b2 inhibition with 9-ING-41 attenuates the progression of pulmonary fibrosis. Scientific Reports 9 (1): 18925. https:\/\/doi.org\/10.1038\/s41598-019-55176-w.","journal-title":"Scientific Reports"},{"issue":"1","key":"2533_CR112","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/excr.1996.0257","volume":"227","author":"L Staiano-Coico","year":"1996","unstructured":"Staiano-Coico, L., K. Carano, V.M. Allan, M.G. Steiner, I. Pagan-Charry, B.B. Bailey, et al. 1996. PAI-1 gene expression is growth state-regulated in cultured human epidermal keratinocytes during progression to confluence and postwounding. Experimental Cell Research 227 (1): 123\u201334. https:\/\/doi.org\/10.1006\/excr.1996.0257.","journal-title":"Experimental Cell Research"},{"issue":"5","key":"2533_CR113","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0002-9440(10)64292-7","volume":"162","author":"TL Tuan","year":"2003","unstructured":"Tuan, T.L., H. Wu, E.Y. Huang, S.S.N. Chong, W. Laug, D. Messadi, et al. 2003. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. The American Journal of Pathology 162 (5): 1579\u201389. https:\/\/doi.org\/10.1016\/S0002-9440(10)64292-7.","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"2533_CR114","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3892\/ijmm.2015.2135","volume":"35","author":"X Ma","year":"2015","unstructured":"Ma, X., J. Chen, B. Xu, X. Long, H. Qin, R.C. Zhao, et al. 2015. Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro. International Journal of Molecular Medicine 35 (5): 1246\u201356. https:\/\/doi.org\/10.3892\/ijmm.2015.2135.","journal-title":"International Journal of Molecular Medicine"},{"key":"2533_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1132353","volume":"10","author":"K Wang","year":"2023","unstructured":"Wang, K., D. Wen, X. Xu, R. Zhao, F. Jiang, S. Yuan, et al. 2023. Extracellular matrix stiffness\u2014The central cue for skin fibrosis. Frontiers in Molecular Biosciences 10: 1132353. https:\/\/doi.org\/10.3389\/fmolb.2023.1132353.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"2533_CR116","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12967-025-06447-w","volume":"23","author":"G Khalili-Tanha","year":"2025","unstructured":"Khalili-Tanha, G., E. S. Radisky, D. C. Radisky, and A. Shoari. 2025. Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease. J Transl Med 23(1):436. https:\/\/doi.org\/10.1186\/s12967-025-06447-w","journal-title":"J Transl Med"},{"issue":"1","key":"2533_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2025.100906","volume":"49","author":"T Takahashi","year":"2026","unstructured":"Takahashi, T., T. Takahashi, and Y. Asano. 2026. Plasminogen activator inhibitor-1 in systemic sclerosis: A nexus of fibrosis, vasculopathy, and senescence. Biomedical Journal 49 (1): 100906. https:\/\/doi.org\/10.1016\/j.bj.2025.100906.","journal-title":"Biomedical Journal"},{"issue":"5","key":"2533_CR118","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1172\/JCI99088","volume":"128","author":"N Pincha","year":"2018","unstructured":"Pincha, N., E.Y. Hajam, K. Badarinath, S.P.R. Batta, T. Masudi, R. Dey, et al. 2018. PAI1 mediates fibroblast\u2013mast cell interactions in skin fibrosis. Journal of Clinical Investigation 128 (5): 1807\u201319. https:\/\/doi.org\/10.1172\/JCI99088.","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"2533_CR119","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S0002-9440(10)63015-5","volume":"159","author":"JCY Chan","year":"2001","unstructured":"Chan, J.C.Y., D.A. Duszczyszyn, F.J. Castellino, and V.A. Ploplis. 2001. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. The American Journal of Pathology 159 (5): 1681\u20138. https:\/\/doi.org\/10.1016\/S0002-9440(10)63015-5.","journal-title":"The American Journal of Pathology"},{"issue":"7","key":"2533_CR120","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.2337\/db14-1174","volume":"64","author":"IA Rebalka","year":"2015","unstructured":"Rebalka, I.A., M.J. Raleigh, D.M. D\u2019Souza, S.K. Coleman, A.N. Rebalka, and T.J. Hawke. 2015. Inhibition of PAI-1 via PAI-039 improves dermal wound closure in diabetes. Diabetes 64 (7): 2593\u2013602. https:\/\/doi.org\/10.2337\/db14-1174.","journal-title":"Diabetes"},{"issue":"4","key":"2533_CR121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041712","volume":"22","author":"LA Miles","year":"2021","unstructured":"Miles, L.A., L. Ny, M. Wilczynska, Y. Shen, T. Ny, and R.J. Parmer. 2021. Plasminogen receptors and fibrinolysis. IJMS 22 (4): 1712. https:\/\/doi.org\/10.3390\/ijms22041712.","journal-title":"IJMS"},{"issue":"10","key":"2533_CR122","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/jth.15014","volume":"18","author":"LA Miles","year":"2020","unstructured":"Miles, L. A., J. P. Vago, L. P. Sousa, and R. J. Parmer. 2020. Functions of the plasminogen receptor Plg-RKT. Journal of Thrombosis and Haemostasis 18(10):2468\u20132481. https:\/\/doi.org\/10.1111\/jth.15014","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"13","key":"2533_CR123","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1128\/JVI.00519-13","volume":"87","author":"A Dziduszko","year":"2013","unstructured":"Dziduszko, A., and M.A. Ozbun. 2013. Annexin A2 and S100A10 regulate Human Papillomavirus Type 16 entry and intracellular trafficking in human keratinocytes. Journal of Virology 87 (13): 7502\u201315. https:\/\/doi.org\/10.1128\/JVI.00519-13.","journal-title":"Journal of Virology"},{"issue":"4","key":"2533_CR124","doi-asserted-by":"publisher","first-page":"e14433","DOI":"10.1111\/acel.14433","volume":"24","author":"X He","year":"2025","unstructured":"He, X., C. Wang, Q. Zhang, T. Yang, Q. Guo, and Y. Wang et al. 2025. Identifying ENO1 as a protein target of chlorogenic acid to inhibit cellular senescence and prevent skin photoaging in mice. Aging Cell 24(4):e14433. https:\/\/doi.org\/10.1111\/acel.14433","journal-title":"Aging Cell"},{"issue":"11","key":"2533_CR125","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.7150\/ijbs.83141","volume":"19","author":"Y Luo","year":"2023","unstructured":"Luo, Y., B. Pang, J. Hao, Q. Li, P. Qiao, and C. Zhang et al. 2023. Keratin 17 covalently binds to alpha-enolase and exacerbates proliferation of keratinocytes in psoriasis. International Journal Of Biological Sciences 19(11):3395\u20133411. https:\/\/doi.org\/10.7150\/ijbs.83141","journal-title":"International Journal Of Biological Sciences"},{"issue":"2","key":"2533_CR126","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/ics.12449","volume":"40","author":"T Tohgasaki","year":"2018","unstructured":"Tohgasaki, T., N. Ozawa, T. Yoshino, S. Ishiwatari, S. Matsukuma, S. Yanagi, et al. 2018. Enolase-1 expression in the stratum corneum is elevated with parakeratosis of atopic dermatitis and disrupts the cellular tight junction barrier in keratinocytes. International Journal of Cosmetic Science 40 (2): 178\u201386. https:\/\/doi.org\/10.1111\/ics.12449.","journal-title":"International Journal of Cosmetic Science"},{"issue":"2","key":"2533_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12020254","volume":"12","author":"M Hippner","year":"2022","unstructured":"Hippner, M., M. Majkowski, P. Biecek, T. Szkudlarek, A. Simiczyjew, M. Pieniazek, et al. 2022. Alpha-Enolase (ENO1) correlates with invasiveness of cutaneous melanoma\u2014an in vitro and a clinical study. Diagnostics 12 (2): 254. https:\/\/doi.org\/10.3390\/diagnostics12020254.","journal-title":"Diagnostics"},{"issue":"4","key":"2533_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2026.100471","volume":"6","author":"X Chen","year":"2026","unstructured":"Chen, X., K. Kuonqui, S. Pal, J. Shin, A. Stull-Lane, G. Ashokan, et al. 2026. Keratinocytes: A key player in skin immunity and their emerging roles in secondary lymphedema. JID Innovations 6 (4): 100471. https:\/\/doi.org\/10.1016\/j.xjidi.2026.100471.","journal-title":"JID Innovations"},{"issue":"3","key":"2533_CR129","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbrc.2010.07.077","volume":"399","author":"Y Yamashiro","year":"2010","unstructured":"Yamashiro, Y., K. Takei, M. Umikawa, T. Asato, M. Oshiro, and Y. Uechi et al. 2010. Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma. Biochemical and Biophysical Research Communications 399(3):365\u2013372. https:\/\/doi.org\/10.1016\/j.bbrc.2010.07.077","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"2533_CR130","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1681\/ASN.2004090771","volume":"16","author":"AL Cochrane","year":"2005","unstructured":"Cochrane, A. L., M. M. Kett, C. S. Samuel, N. V. Campanale, W. P. Anderson, and D. A. Hume et al. 2005. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. Journal of the American Society of Nephrology: JASN 16(12):3623\u20133630. 10. 1681\/ASN.2004090771 PubMed PMID: 16221872.","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"2533_CR131","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-005-1995-5","author":"AA Eddy","year":"2005","unstructured":"Eddy, A.A. 2005. Can renal fibrosis be reversed? Pediatric Nephrology. https:\/\/doi.org\/10.1007\/s00467-005-1995-5.","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"2533_CR132","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0306-9877(97)90253-x","volume":"49","author":"PJ du Toit","year":"1997","unstructured":"du Toit, P.J., C.H. Van Aswegen, C.M. Steinmann, L. Klue, and D.J. Du Plessis. 1997. Does urokinase play a role in renal stone formation? Medical Hypotheses 49 (1): 57\u20139. https:\/\/doi.org\/10.1016\/s0306-9877(97)90253-x.","journal-title":"Medical Hypotheses"},{"issue":"5","key":"2533_CR133","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1046\/j.1523-1755.2003.00261.x","volume":"64","author":"JJTH Roelofs","year":"2003","unstructured":"Roelofs, J.J.T.H., A.T. Rowshani, J.G. van den Berg, N. Claessen, J. Aten, I.J.M. ten Berge, et al. 2003. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection. Kidney International 64 (5): 1845\u201353. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00261.x.","journal-title":"Kidney International"},{"issue":"5","key":"2533_CR134","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/01.asn.0000064292.37793.fb","volume":"14","author":"G Zhang","year":"2003","unstructured":"Zhang, G., H. Kim, X. Cai, J.M. L\u00f3pez-Guisa, C.E. Alpers, Y. Liu, et al. 2003. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. Journal of the American Society of Nephrology\u202f: JASN 14 (5): 1254\u201371. https:\/\/doi.org\/10.1097\/01.asn.0000064292.37793.fb.","journal-title":"Journal of the American Society of Nephrology : JASN"},{"issue":"3","key":"2533_CR135","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2006080886","volume":"18","author":"G Zhang","year":"2007","unstructured":"Zhang, G., K.A. Kernan, S.J. Collins, X. Cai, J.M. L\u00f3pez-Guisa, J.L. Degen, et al. 2007. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: Role of plasmin-activated signals. Journal of the American Society of Nephrology 18 (3): 846\u201359. https:\/\/doi.org\/10.1681\/ASN.2006080886.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"2533_CR136","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/j.1523-1755.2005.00500.x","volume":"68","author":"Y Nishitani","year":"2005","unstructured":"Nishitani, Y., M. Iwano, Y. Yamaguchi, K. Harada, K. Nakatani, Y. Akai, et al. 2005. Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney International 68 (3): 1078\u201385. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00500.x.","journal-title":"Kidney International"},{"issue":"13","key":"2533_CR137","doi-asserted-by":"publisher","DOI":"10.2741\/3093","volume":"Volume","author":"G Zhang","year":"2008","unstructured":"Zhang, G. 2008. Urokinase and its receptors in chronic kidney disease. Frontiers in Bioscience Volume (13): 5462. https:\/\/doi.org\/10.2741\/3093.","journal-title":"Frontiers in Bioscience"},{"issue":"21","key":"2533_CR138","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1042\/CS20200923","volume":"134","author":"SWY Lok","year":"2020","unstructured":"Lok, S.W.Y., W.H. Yiu, H. Li, R. Xue, Y. Zou, B. Li, et al. 2020. The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis. Clinical Science 134 (21): 2873\u201391. https:\/\/doi.org\/10.1042\/CS20200923.","journal-title":"Clinical Science"},{"issue":"2","key":"2533_CR139","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/jcmm.14028","volume":"23","author":"M Waasdorp","year":"2019","unstructured":"Waasdorp, M., D.M. De Rooij, S. Florquin, J. Duitman, and C.A. Spek. 2019. Protease-activated receptor\u20101 contributes to renal injury and interstitial fibrosis during chronic obstructive nephropathy. J Cellular Molecular Medi 23 (2): 1268\u201379. https:\/\/doi.org\/10.1111\/jcmm.14028.","journal-title":"J Cellular Molecular Medi"},{"issue":"6","key":"2533_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061167","volume":"12","author":"M Hamada","year":"2024","unstructured":"Hamada, M., K.S. Varkoly, O. Riyadh, R. Beladi, G. Munuswamy-Ramanujam, A. Rawls, et al. 2024. Urokinase-type plasminogen activator receptor (uPAR) in inflammation and disease: A unique inflammatory pathway activator. Biomedicines 12 (6): 1167. https:\/\/doi.org\/10.3390\/biomedicines12061167.","journal-title":"Biomedicines"},{"issue":"12","key":"2533_CR141","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1681\/ASN.2008050513","volume":"19","author":"EM Zeisberg","year":"2008","unstructured":"Zeisberg, E.M., S.E. Potenta, H. Sugimoto, M. Zeisberg, and R. Kalluri. 2008. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. Journal of the American Society of Nephrology 19 (12): 2282\u20137. https:\/\/doi.org\/10.1681\/ASN.2008050513.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"2533_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06154-0","volume":"7","author":"C Xu","year":"2024","unstructured":"Xu, C., J. Chen, L. Liang, S. Chen, X. Niu, R. Sang, et al. 2024. Midkine promotes renal fibrosis by stabilizing C\/EBP\u03b2 to facilitate endothelial-mesenchymal transition. Communications Biology 7 (1): 544. https:\/\/doi.org\/10.1038\/s42003-024-06154-0.","journal-title":"Communications Biology"},{"key":"2533_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116477","volume":"229","author":"S Chen","year":"2024","unstructured":"Chen, S., Q. He, H. Yang, and H. Huang. 2024. Endothelial Birc3 promotes renal fibrosis through modulating Drp1-mediated mitochondrial fission via MAPK\/PI3K\/Akt pathway. Biochemical Pharmacology 229: 116477. https:\/\/doi.org\/10.1016\/j.bcp.2024.116477.","journal-title":"Biochemical Pharmacology"},{"issue":"21","key":"2533_CR144","doi-asserted-by":"publisher","DOI":"10.1172\/JCI190286","volume":"135","author":"R Pietil\u00e4","year":"2025","unstructured":"Pietil\u00e4, R., A. Marks-Hultstr\u00f6m, L. He, S. Nanavazadeh, S.E. Quaggin, C. Betsholtz, et al. 2025. TIE2 activation by antibody-clustered endogenous angiopoietin-2 prevents capillary loss and fibrosis in experimental kidney disease. Journal of Clinical Investigation 135 (21): e190286. https:\/\/doi.org\/10.1172\/JCI190286.","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"2533_CR145","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","volume":"92","author":"S Meran","year":"2011","unstructured":"Meran, S., and R. Steadman. 2011. Fibroblasts and myofibroblasts in renal fibrosis: Fibroblasts and myofibroblasts in renal fibrosis. International Journal of Experimental Pathology 92 (3): 158\u201367. https:\/\/doi.org\/10.1111\/j.1365-2613.2011.00764.x.","journal-title":"International Journal of Experimental Pathology"},{"issue":"3","key":"2533_CR146","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3892\/ijmm.2013.1234","volume":"31","author":"S Ma\u0142gorzewicz","year":"2013","unstructured":"Ma\u0142gorzewicz, S., E. Skrzypczak-Jankun, and J. Jankun. 2013. Plasminogen activator inhibitor-1 in kidney pathology. International Journal of Molecular Medicine 31(3):503\u2013510. https:\/\/doi.org\/10.3892\/ijmm.2013.1234","journal-title":"International Journal of Molecular Medicine"},{"issue":"1","key":"2533_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52214-8","volume":"15","author":"A Elwakiel","year":"2024","unstructured":"Elwakiel, A., D. Gupta, R. Rana, J. Manoharan, M.M. Al-Dabet, S. Ambreen, et al. 2024. Factor XII signaling via uPAR-integrin \u03b21 axis promotes tubular senescence in diabetic kidney disease. Nature Communications 15 (1): 7963. https:\/\/doi.org\/10.1038\/s41467-024-52214-8.","journal-title":"Nature Communications"},{"issue":"2","key":"2533_CR148","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2273427","volume":"45","author":"J Lei","year":"2023","unstructured":"Lei, J., P. Sun, J. Sheng, H. Wang, Y. Xie, and J. Song. 2023. The intricate role of annexin A2 in kidney: A comprehensive review. Renal Failure 45 (2): 2273427. https:\/\/doi.org\/10.1080\/0886022X.2023.2273427.","journal-title":"Renal Failure"},{"issue":"6","key":"2533_CR149","doi-asserted-by":"publisher","first-page":"F821","DOI":"10.1152\/ajprenal.00356.2013","volume":"305","author":"RJ Tan","year":"2013","unstructured":"Tan, R. J., and Y. Liu. 2013. Macrophage-derived TGF-\u03b2 in renal fibrosis: not a macro-impact after all. American Journal of Physiology-Renal Physiology 305(6):F821\u2013F822. https:\/\/doi.org\/10.1152\/ajprenal.00356.2013","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"2533_CR150","doi-asserted-by":"publisher","unstructured":"Lin, L., E. Richardson, and K. Hu. 2024. Abstract 4140279: Myeloid\/Macrophage Annexin A2 Promotes Kidney Fibrosis. Circulation 150(Suppl1). https:\/\/doi.org\/10.1161\/circ.150.suppl_1.4140279","DOI":"10.1161\/circ.150.suppl_1.4140279"},{"issue":"10","key":"2533_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110657","volume":"301","author":"B Renner","year":"2025","unstructured":"Renner, B., J. Laskowski, F. Poppelaars, R. Whelan, K. Milliron, V. Petr, et al. 2025. Annexin A2 interferes with complement regulation within the glomerulus. Journal of Biological Chemistry 301 (10): 110657. https:\/\/doi.org\/10.1016\/j.jbc.2025.110657.","journal-title":"Journal of Biological Chemistry"},{"issue":"18","key":"2533_CR152","doi-asserted-by":"publisher","first-page":"13561","DOI":"10.1074\/jbc.M610184200","volume":"282","author":"H G\u00e5rdsvoll","year":"2007","unstructured":"G\u00e5rdsvoll, H., and M. Ploug. 2007. Mapping of the vitronectin-binding site on the urokinase receptor: Involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region. The Journal of Biological Chemistry 282 (18): 13561\u201372. https:\/\/doi.org\/10.1074\/jbc.M610184200.","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"2533_CR153","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1097\/01.ASN.0000135057.41526.2C","volume":"15","author":"G Zhang","year":"2004","unstructured":"Zhang, G., X. Cai, J. M. L\u00f3pez-Guisa, S. J. Collins, and A. A. Eddy. 2004. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. Journal of the American Society of Nephrology: JASN 15(8):2090\u20132102. 2\u00a0C PubMed PMID: 15284295.","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"42","key":"2533_CR154","doi-asserted-by":"publisher","first-page":"29050","DOI":"10.1074\/jbc.M109.010249","volume":"284","author":"G Zhang","year":"2009","unstructured":"Zhang, G., K. A. Kernan, A. Thomas, S. Collins, Y. Song, and L. Li et al. 2009. A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis. The Journal of biological chemistry 284(42):29050\u201329064. https:\/\/doi.org\/10.1074\/jbc.M109.010249 . PubMed PMID: 19690163.","journal-title":"The Journal of biological chemistry"},{"key":"2533_CR155","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.2741\/3093","volume":"13","author":"G Zhang","year":"2008","unstructured":"Zhang, G., and A.A. Eddy. 2008. Urokinase and its receptors in chronic kidney disease. Frontiers in Bioscience\u202f: A Journal and Virtual Library 13: 5462\u201378. https:\/\/doi.org\/10.2741\/3093.","journal-title":"Frontiers in Bioscience : A Journal and Virtual Library"},{"key":"2533_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.974381","volume":"10","author":"L Lin","year":"2022","unstructured":"Lin, L., and K. Hu. 2022. Annexin A2 and kidney diseases. Frontiers in Cell and Developmental Biology 10: 974381. https:\/\/doi.org\/10.3389\/fcell.2022.974381.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"7","key":"2533_CR157","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T., and S.L. Friedman. 2017. Mechanisms of hepatic stellate cell activation. Nature Reviews Gastroenterology & Hepatology 14 (7): 397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"3","key":"2533_CR158","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0002-9440(10)64039-4","volume":"158","author":"JA Bezerra","year":"2001","unstructured":"Bezerra, J.A., A.R. Currier, H. Melin-Aldana, G. Sabla, T.H. Bugge, K.W. Kombrinck, et al. 2001. Plasminogen activators direct reorganization of the liver lobule after acute injury. The American Journal of Pathology 158 (3): 921\u20139. https:\/\/doi.org\/10.1016\/S0002-9440(10)64039-4.","journal-title":"The American Journal of Pathology"},{"issue":"6470","key":"2533_CR159","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/368419a0","volume":"368","author":"P Carmeliet","year":"1994","unstructured":"Carmeliet, P., L. Schoonjans, L. Kieckens, B. Ream, J. Degen, and R. Bronson et al. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368(6470):419\u2013424. https:\/\/doi.org\/10.1038\/368419a0 . PubMed PMID: 8133887.","journal-title":"Nature"},{"issue":"1","key":"2533_CR160","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-40","volume":"6","author":"K Shanmukhappa","year":"2006","unstructured":"Shanmukhappa, K., G.E. Sabla, J.L. Degen, and J.A. Bezerra. 2006. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor. BMC Gastroenterology 6 (1): 40. https:\/\/doi.org\/10.1186\/1471-230X-6-40.","journal-title":"BMC Gastroenterology"},{"issue":"6","key":"2533_CR161","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/S0002-9440(10)63069-6","volume":"159","author":"JF Pohl","year":"2001","unstructured":"Pohl, J.F., H. Melin-Aldana, G. Sabla, J.L. Degen, and J.A. Bezerra. 2001. Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury. The American Journal of Pathology 159 (6): 2179\u201386. https:\/\/doi.org\/10.1016\/S0002-9440(10)63069-6.","journal-title":"The American Journal of Pathology"},{"issue":"6","key":"2533_CR162","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3748\/wjg.v22.i6.2092","volume":"22","author":"ZG Ma","year":"2016","unstructured":"Ma, Z.G., X.D. Lv, L.L. Zhan, L. Chen, Q.Y. Zou, and J.Q. Xiang. 2016. Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway. World Journal of Gastroenterology 22 (6): 2092\u2013103. https:\/\/doi.org\/10.3748\/wjg.v22.i6.2092.","journal-title":"World Journal of Gastroenterology"},{"issue":"1","key":"2533_CR163","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2007.12.085","volume":"367","author":"C Kordes","year":"2008","unstructured":"Kordes, C., I. Sawitza, and D. H\u00e4ussinger. 2008. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochemical and Biophysical Research Communications 367 (1): 116\u201323. https:\/\/doi.org\/10.1016\/j.bbrc.2007.12.085.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"10","key":"2533_CR164","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/labinvest.2015.94","volume":"95","author":"LI Kang","year":"2015","unstructured":"Kang, L.I., K. Isse, K. Koral, W.C. Bowen, S. Muratoglu, D.K. Strickland, et al. 2015. Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1. Laboratory Investigation 95 (10): 1117\u201329. https:\/\/doi.org\/10.1038\/labinvest.2015.94.","journal-title":"Laboratory Investigation"},{"issue":"1","key":"2533_CR165","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jhep.2003.09.016","volume":"40","author":"K Okada","year":"2004","unstructured":"Okada, K., S. Ueshima, M. Imano, K. Kataoka, and O. Matsuo. 2004. The regulation of liver regeneration by the plasmin\/\u03b12-antiplasmin system. Journal of Hepatology 40 (1): 110\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2003.09.016.","journal-title":"Journal of Hepatology"},{"issue":"4","key":"2533_CR166","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/s0168-8278(99)80351-1","volume":"31","author":"LP Zhang","year":"1999","unstructured":"Zhang, L.P., T. Takahara, Y. Yata, K. Furui, B. Jin, N. Kawada, et al. 1999. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: Role of stellate cells. Journal of Hepatology 31 (4): 703\u201311. https:\/\/doi.org\/10.1016\/s0168-8278(99)80351-1.","journal-title":"Journal of Hepatology"},{"issue":"11","key":"2533_CR167","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1172\/JCI119815","volume":"100","author":"DE Clouthier","year":"1997","unstructured":"Clouthier, D.E., S.A. Comerford, and R.E. Hammer. 1997. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. The Journal of Clinical Investigation 100 (11): 2697\u2013713. https:\/\/doi.org\/10.1172\/JCI119815.","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"2533_CR168","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/hep.28776","volume":"65","author":"V Ajmera","year":"2017","unstructured":"Ajmera, V., E.R. Perito, N.M. Bass, N.A. Terrault, K.P. Yates, R. Gill, et al. 2017. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 65 (1): 65\u201377. https:\/\/doi.org\/10.1002\/hep.28776.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"16","key":"2533_CR169","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.febslet.2007.05.049","volume":"581","author":"H Wang","year":"2007","unstructured":"Wang, H., Y. Zhang, and R.O. Heuckeroth. 2007. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA. FEBS Letters 581 (16): 3098\u2013104. https:\/\/doi.org\/10.1016\/j.febslet.2007.05.049.","journal-title":"FEBS Letters"},{"issue":"1","key":"2533_CR170","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jhep.2009.02.025","volume":"51","author":"PF Hu","year":"2009","unstructured":"Hu, P.F., H. Chen, W. Zhong, Y. Lin, X. Zhang, Y.X. Chen, et al. 2009. Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. Journal of Hepatology 51 (1): 102\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2009.02.025.","journal-title":"Journal of Hepatology"},{"issue":"5","key":"2533_CR171","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/hep.510240532","volume":"24","author":"H Leyland","year":"1996","unstructured":"Leyland, H., J. Gentry, M.J. Arthur, and R.C. Benyon. 1996. The plasminogen-activating system in hepatic stellate cells. Hepatology 24 (5): 1172\u20138. https:\/\/doi.org\/10.1002\/hep.510240532.","journal-title":"Hepatology"},{"issue":"3","key":"2533_CR172","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/stem.150190","volume":"15","author":"PE Gleizes","year":"1997","unstructured":"Gleizes, P. E., J. S. Munger, I. Nunes, J. G. Harpel, R. Mazzieri, and I. Noguera et al. 1997. TGF-beta latency: biological significance and mechanisms of activation. Stem cells (Dayton. Ohio) 15(3):190\u2013197. https:\/\/doi.org\/10.1002\/stem.150190 . PubMed PMID: 9170210.","journal-title":"Ohio)"},{"issue":"8","key":"2533_CR173","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nm0898-923","volume":"4","author":"K Bajou","year":"1998","unstructured":"Bajou, K., A. No\u00ebl, R.D. Gerard, V. Masson, N. Brunner, C. Holst-Hansen, et al. 1998. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Medicine 4 (8): 923\u20138. https:\/\/doi.org\/10.1038\/nm0898-923.","journal-title":"Nature Medicine"},{"key":"2533_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071716","author":"H Kurose","year":"2021","unstructured":"Kurose, H. 2021. Cardiac fibrosis and fibroblasts. Cells. https:\/\/doi.org\/10.3390\/cells10071716.","journal-title":"Cells"},{"issue":"3","key":"2533_CR175","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","volume":"4","author":"C Humeres","year":"2019","unstructured":"Humeres, C., and N.G. Frangogiannis. 2019. Fibroblasts in the infarcted, remodeling, and failing heart. JACC Basic to translational science 4 (3): 449\u201367. https:\/\/doi.org\/10.1016\/j.jacbts.2019.02.006.","journal-title":"JACC Basic to translational science"},{"issue":"1","key":"2533_CR176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S.D., and N.G. Frangogiannis. 2016. The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circulation Research 119 (1): 91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577.","journal-title":"Circulation Research"},{"key":"2533_CR177","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.yjmcc.2015.11.002","volume":"94","author":"NA Turner","year":"2016","unstructured":"Turner, N.A. 2016. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). Journal of Molecular and Cellular Cardiology 94: 189\u2013200. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.11.002.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"6885","key":"2533_CR178","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/417182a","volume":"417","author":"R Hanayama","year":"2002","unstructured":"Hanayama, R., M. Tanaka, K. Miwa, A. Shinohara, A. Iwamatsu, and S. Nagata. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417(6885):182\u2013187. https:\/\/doi.org\/10.1038\/417182a","journal-title":"Nature"},{"key":"2533_CR179","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yjmcc.2015.11.005","volume":"93","author":"MA Horn","year":"2016","unstructured":"Horn, M.A., and A.W. Trafford. 2016. Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling. Journal of Molecular and Cellular Cardiology 93: 175\u201385. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.11.005.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1","key":"2533_CR180","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-020-00840-w","volume":"116","author":"C Baumeier","year":"2021","unstructured":"Baumeier, C., F. Escher, G. Aleshcheva, H. Pietsch, and H.P. Schultheiss. 2021. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy. Basic Research in Cardiology 116 (1): 1. https:\/\/doi.org\/10.1007\/s00395-020-00840-w.","journal-title":"Basic Research in Cardiology"},{"issue":"1","key":"2533_CR181","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ydbio.2003.08.026","volume":"265","author":"S Krishnan","year":"2004","unstructured":"Krishnan, S., A.B. Deora, J.P. Annes, J. Osoria, D.B. Rifkin, and K.A. Hajjar. 2004. Annexin II-mediated plasmin generation activates TGF-\u03b23 during epithelial\u2013mesenchymal transformation in the developing avian heart. Developmental Biology 265 (1): 140\u201354. https:\/\/doi.org\/10.1016\/j.ydbio.2003.08.026.","journal-title":"Developmental Biology"},{"issue":"5","key":"2533_CR182","doi-asserted-by":"publisher","first-page":"e63825","DOI":"10.1371\/journal.pone.0063825","volume":"8","author":"AK Ghosh","year":"2013","unstructured":"Ghosh, A. K., S. B. Murphy, R. Kishore, and D. E. Vaughan. 2013. Global Gene Expression Profiling in PAI-1 Knockout Murine Heart and Kidney: Molecular Basis of Cardiac-Selective Fibrosis. PLOS ONE 8(5):e63825.","journal-title":"PLOS ONE"},{"key":"2533_CR183","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.redox.2017.12.016","volume":"15","author":"Y Xin","year":"2018","unstructured":"Xin, Y., Y. Bai, X. Jiang, S. Zhou, Y. Wang, K.A. Wintergerst, et al. 2018. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt\/GSK-3\u00df\/Fyn pathway. Redox Biology 15: 405\u201317. https:\/\/doi.org\/10.1016\/j.redox.2017.12.016.","journal-title":"Redox Biology"},{"issue":"1","key":"2533_CR184","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2016.193","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi, Y., L. Du, L. Lin, and Y. Wang. 2017. Tumour-associated mesenchymal stem\/stromal cells: Emerging therapeutic targets. Nature Reviews Drug Discovery 16 (1): 35\u201352. https:\/\/doi.org\/10.1038\/nrd.2016.193.","journal-title":"Nature Reviews Drug Discovery"},{"issue":"9","key":"2533_CR185","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. 2016. The biology and function of fibroblasts in cancer. Nature Reviews Cancer 16 (9): 582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nature Reviews Cancer"},{"issue":"9","key":"2533_CR186","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth, N., M.S. Wicha, and W. Zou. 2017. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews Immunology 17 (9): 559\u201372. https:\/\/doi.org\/10.1038\/nri.2017.49.","journal-title":"Nature Reviews Immunology"},{"issue":"5","key":"2533_CR187","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","volume":"165","author":"W Wang","year":"2016","unstructured":"Wang, W., I. Kryczek, L. Dost\u00e1l, H. Lin, L. Tan, L. Zhao, et al. 2016. Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer. Cell 165 (5): 1092\u2013105. https:\/\/doi.org\/10.1016\/j.cell.2016.04.009.","journal-title":"Cell"},{"issue":"30","key":"2533_CR188","doi-asserted-by":"publisher","first-page":"47720","DOI":"10.18632\/oncotarget.10279","volume":"7","author":"PA Madureira","year":"2016","unstructured":"Madureira, P.A., A.G. Bharadwaj, M. Bydoun, K. Garant, P. O\u2019Connell, P. Lee, et al. 2016. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10. Oncotarget 7 (30): 47720\u201337. https:\/\/doi.org\/10.18632\/oncotarget.10279.","journal-title":"Oncotarget"},{"issue":"15","key":"2533_CR189","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.7150\/jca.87689","volume":"14","author":"YC Zhao","year":"2023","unstructured":"Zhao, Y.C., T.J. Wang, L.Z. She, J. Cui, and C.H. Zhang. 2023. S100A10 overexpression correlates with adverse prognosis, tumor microenvironment, and aggressive behavior in vitro and in vivo of cervical cancer. Journal of Cancer 14 (15): 2931\u201345. https:\/\/doi.org\/10.7150\/jca.87689.","journal-title":"Journal of Cancer"},{"issue":"2","key":"2533_CR190","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ctrv.2007.10.005","volume":"34","author":"K Dass","year":"2008","unstructured":"Dass, K., A. Ahmad, A. S. Azmi, S. H. Sarkar, and F. H. Sarkar. 2008. Evolving role of uPA\/uPAR system in human cancers. Cancer Treatment Reviews 34(2):122\u2013136. https:\/\/doi.org\/10.1016\/j.ctrv.2007.10.005","journal-title":"Cancer Treatment Reviews"},{"key":"2533_CR191","unstructured":"Fisher, J. L., P. S. Mackie, M. L. Howard, H. Zhou, and P. F. M. Choong. 2001. The expression of the Urokinase plasminogen activator system in metastatic murine osteosarcoma. Clinical Cancer Research. 7(6):1654 LP \u2013 1660."},{"issue":"1","key":"2533_CR192","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/bcr1647","volume":"9","author":"GE Stillfried","year":"2007","unstructured":"Stillfried, G.E., D.N. Saunders, and M. Ranson. 2007. Plasminogen binding and activation at the breast cancer cell surface: The integral role of urokinase activity. Breast cancer research\u202f: BCR 9 (1): R14\u2013R14. https:\/\/doi.org\/10.1186\/bcr1647.","journal-title":"Breast cancer research : BCR"},{"issue":"17","key":"2533_CR193","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.yexcr.2010.04.032","volume":"316","author":"K R\u00e4s\u00e4nen","year":"2010","unstructured":"R\u00e4s\u00e4nen, K., and A. Vaheri. 2010. Activation of fibroblasts in cancer stroma. Experimental Cell Research 316 (17): 2713\u201322. https:\/\/doi.org\/10.1016\/j.yexcr.2010.04.032.","journal-title":"Experimental Cell Research"},{"issue":"1","key":"2533_CR194","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.cr.7310010","volume":"16","author":"SY Yoon","year":"2006","unstructured":"Yoon, S.Y., Y.J. Lee, J.H. Seo, H.J. Sung, K.H. Park, I.K. Choi, et al. 2006. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line. Cell Research 16 (1): 75\u201381. https:\/\/doi.org\/10.1038\/sj.cr.7310010.","journal-title":"Cell Research"},{"issue":"26","key":"2533_CR195","doi-asserted-by":"publisher","first-page":"42300","DOI":"10.18632\/oncotarget.15857","volume":"8","author":"B Tian","year":"2017","unstructured":"Tian, B., X. Chen, H. Zhang, X. Li, J. Wang, W. Han, et al. 2017. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K\/AKT and ERK signaling in esophageal squamous cell carcinoma. Oncotarget 8 (26): 42300\u201313. https:\/\/doi.org\/10.18632\/oncotarget.15857.","journal-title":"Oncotarget"},{"issue":"1","key":"2533_CR196","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12885-017-3183-y","volume":"17","author":"S Ciavarella","year":"2017","unstructured":"Ciavarella, S., A. Laurenzana, S. De Summa, B. Pilato, A. Chill\u00e0, R. Lacalamita, et al. 2017. u-PAR expression in cancer associated fibroblast: New acquisitions in multiple myeloma progression. BMC Cancer 17 (1): 215. https:\/\/doi.org\/10.1186\/s12885-017-3183-y.","journal-title":"BMC Cancer"},{"issue":"4","key":"2533_CR197","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0002-9440(10)64637-8","volume":"157","author":"E Dublin","year":"2000","unstructured":"Dublin, E., A. Hanby, N. K. Patel, R. Liebman, and D. Barnes. 2000. Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology. The American journal of pathology 157(4):1219\u20131227. https:\/\/doi.org\/10.1016\/S0002-9440(10)64637-8","journal-title":"The American journal of pathology"},{"issue":"1\u20132","key":"2533_CR198","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.bjc.6690336","volume":"80","author":"T Jahkola","year":"1999","unstructured":"Jahkola, T., T. Toivonen, K. von Smitten, I. Virtanen, V.M. Wasenius, and C. Blomqvist. 1999. Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: An immunohistochemical study of prognostic value and relations to tenascin-C and other factors. British Journal of Cancer 80 (1\u20132): 167\u201374. https:\/\/doi.org\/10.1038\/sj.bjc.6690336.","journal-title":"British Journal of Cancer"},{"key":"2533_CR199","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/5584_2019_353","volume":"1153","author":"J Teliga-Czajkowska","year":"2019","unstructured":"Teliga-Czajkowska, J., J. Sienko, K. Jalinik, P. Derlatka, A. Danska-Bidzinska, and K. Czajkowski. 2019. Plasminogen activator inhibitor type 1 in blood at onset of chemotherapy unfavorably affects survival in primary ovarian cancer. Advances in Experimental Medicine and Biology 1153: 47\u201354. https:\/\/doi.org\/10.1007\/5584_2019_353.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"4","key":"2533_CR200","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1160\/TH05-01-0011","volume":"94","author":"MU R\u00f8mer","year":"2005","unstructured":"R\u00f8mer, M. U., A. Kirkebjerg Due, J. Knud Larsen, K. F. Hofland, I. J. Christensen, and P. Buhl-Jensen et al. 2005. Indication of a role of plasminogen activator inhibitor type I in protecting murine fibrosarcoma cells against apoptosis. Thrombosis and haemostasis 94(4):859\u2013866.","journal-title":"Thrombosis and haemostasis"},{"issue":"7","key":"2533_CR201","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41419-018-0808-2","volume":"9","author":"Y Che","year":"2018","unstructured":"Che, Y., J. Wang, Y. Li, Z. Lu, J. Huang, and S. Sun et al. 2018. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance. Cell death & disease 9(7):759. https:\/\/doi.org\/10.1038\/s41419-018-0808-2 . PubMed PMID: 29988148.","journal-title":"Cell death & disease"},{"issue":"1","key":"2533_CR202","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13075-018-1526-y","volume":"20","author":"J Qian","year":"2018","unstructured":"Qian, J., L. Xu, X. Sun, Y. Wang, W. Xuan, and Q. Zhang et al. 2018. Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis. Arthritis research & therapy 20(1):26. https:\/\/doi.org\/10.1186\/s13075-018-1526-y . PubMed PMID: 29422077.","journal-title":"Arthritis research & therapy"},{"issue":"12","key":"2533_CR203","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nm.2050","volume":"15","author":"S Lef\u00e8vre","year":"2009","unstructured":"Lef\u00e8vre, S., A. Knedla, C. Tennie, A. Kampmann, C. Wunrau, and R. Dinser et al. 2009. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nature medicine 15(12):1414\u20131420. 10.1038. \/nm.2050 PubMed PMID: 19898488.","journal-title":"Nature medicine"},{"issue":"4","key":"2533_CR204","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00281-017-0631-3","volume":"39","author":"Asif M. Amin","year":"2017","unstructured":"Amin, Asif M.., D.A. Fox, and J.H. Ruth. 2017. Synovial cellular and molecular markers in rheumatoid arthritis. Seminars in Immunopathology 39 (4): 385\u201393. https:\/\/doi.org\/10.1007\/s00281-017-0631-3.","journal-title":"Seminars in Immunopathology"},{"issue":"2","key":"2533_CR205","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1381612820666140825122036","volume":"21","author":"S Lefevre","year":"2015","unstructured":"Lefevre, S., F.M.P. Meier, E. Neumann, and U. Muller-Ladner. 2015. Role of synovial fibroblasts in rheumatoid arthritis. Current Pharmaceutical Design 21 (2): 130\u201341. https:\/\/doi.org\/10.2174\/1381612820666140825122036.","journal-title":"Current Pharmaceutical Design"},{"key":"2533_CR206","doi-asserted-by":"publisher","unstructured":"Orr, C., E. Vieira-Sousa, D.L. Boyle, M.H. Buch, C.D. Buckley, J.D. Ca\u00f1ete, et al. 2017. Synovial tissue research: A state-of-the-art review. Nature reviews. Rheumatology. https:\/\/doi.org\/10.1038\/nrrheum.2017.161.","DOI":"10.1038\/nrrheum.2017.161"},{"issue":"12","key":"2533_CR207","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/eji.201646788","volume":"47","author":"V Schmitt","year":"2017","unstructured":"Schmitt, V., M. Hahn, V. K\u00e4stele, O. Wagner, M. Wiendl, A. Derer, et al. 2017. Interleukin-36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts. European Journal of Immunology 47 (12): 2101\u201312. https:\/\/doi.org\/10.1002\/eji.201646788.","journal-title":"European Journal of Immunology"},{"issue":"1","key":"2533_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02935-4","volume":"9","author":"M Armaka","year":"2018","unstructured":"Armaka, M., C. Ospelt, M. Pasparakis, and G. Kollias. 2018. The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts. Nature Communications 9 (1): 618. https:\/\/doi.org\/10.1038\/s41467-018-02935-4.","journal-title":"Nature Communications"},{"issue":"11","key":"2533_CR209","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/bies.20306","volume":"27","author":"T Ludwig","year":"2005","unstructured":"Ludwig, T. 2005. Local proteolytic activity in tumor cell invasion and metastasis. BioEssays 27 (11): 1181\u201391. https:\/\/doi.org\/10.1002\/bies.20306.","journal-title":"BioEssays"},{"issue":"4","key":"2533_CR210","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.ATV.0000209518.58252.17","volume":"26","author":"VWM van Hinsbergh","year":"2006","unstructured":"van Hinsbergh, V.W.M., M.A. Engelse, and P.H.A. Quax. 2006. Pericellular proteases in angiogenesis and vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 26 (4): 716\u201328. https:\/\/doi.org\/10.1161\/01.ATV.0000209518.58252.17.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"3","key":"2533_CR211","first-page":"364","volume":"23","author":"S Guiducci","year":"2005","unstructured":"Guiducci, S., A. Del Rosso, M. Cinelli, F. Margheri, S. D\u2019Alessio, and G. Fibbi et al. 2005. Rheumatoid synovial fibroblasts constitutively express the fibrinolytic pattern of invasive tumor-like cells. Clinical and experimental rheumatology 23(3):364\u2013372. PubMed PMID: 15971425.","journal-title":"Clinical and experimental rheumatology"},{"issue":"9","key":"2533_CR212","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/art.10498","volume":"46","author":"N Busso","year":"2002","unstructured":"Busso, N., and J.A. Hamilton. 2002. Extravascular coagulation and the plasminogen activator\/plasmin system in rheumatoid arthritis. Arthritis and Rheumatism 46 (9): 2268\u201379.","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"2533_CR213","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/s101650200027","volume":"12","author":"T Nonaka","year":"2002","unstructured":"Nonaka, T., H. Kikuchi, S. Sohen, K. Fukuda, C. Hamanishi, and S. Tanaka. 2002. Comparison of the inhibitory effects of two types (90 kDa and 190 kDa) of hyaluronic acid on the expression of fibrinolytic factors in human synovial fibroblasts. Modern Rheumatology 12 (2): 160\u20136. https:\/\/doi.org\/10.3109\/s101650200027.","journal-title":"Modern Rheumatology"},{"issue":"8","key":"2533_CR214","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/art.23610","volume":"58","author":"T Laragione","year":"2008","unstructured":"Laragione, T., M. Brenner, A. Mello, M. Symons, and P. S. Gulko. 2008. The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts. Arthritis and rheumatism 58(8):2296\u20132306. https:\/\/doi.org\/10.1002\/art.23610","journal-title":"Arthritis and rheumatism"},{"key":"2533_CR215","doi-asserted-by":"publisher","unstructured":"Wang, Q., G. Shao, X. Zhao, H. H. Wong, K. Chin, and M. Zhao et al. 2024. Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis. JCI insight 9(8). https:\/\/doi.org\/10.1172\/jci.insight.173603 .","DOI":"10.1172\/jci.insight.173603"},{"issue":"1","key":"2533_CR216","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/07853890903376280","volume":"42","author":"B Svensson","year":"2010","unstructured":"Svensson, B., I. Hafstr\u00f6m, K. Forslind, K. Albertsson, A. Tarkowski, and M. Bokarewa. 2010. Increased expression of proto-oncogene survivin predicts joint destruction and persistent disease activity in early rheumatoid arthritis. Annals of Medicine 42 (1): 45\u201354. https:\/\/doi.org\/10.3109\/07853890903376280.","journal-title":"Annals of Medicine"},{"issue":"9","key":"2533_CR217","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1111\/j.1582-4934.2009.00721.x","volume":"13","author":"M Baran","year":"2009","unstructured":"Baran, M., L. Nilsson, S. Andersson, Imarie Jonsson, AkarinH. Ekwall, J. Bjersing, et al. 2009. Survivin is an essential mediator of arthritis interacting with urokinase signalling. Journal of Cellular and Molecular Medicine 13 (9): 3797\u2013808. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00721.x.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"9","key":"2533_CR218","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/art.30439","volume":"63","author":"S Serrat\u00ec","year":"2011","unstructured":"Serrat\u00ec, S., F. Margheri, A. Chill\u00e0, E. Neumann, U. M\u00fcller-Ladner, M. Benucci, et al. 2011. Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism 63 (9): 2584\u201394. https:\/\/doi.org\/10.1002\/art.30439.","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"2533_CR219","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/cmi.2016.60","volume":"15","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Y.F. Pan, Y.Q. Xue, L.K. Fang, X.H. Guo, X. Guo, et al. 2018. uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K\/Akt signaling pathway in patients with rheumatoid arthritis. Cellular & Molecular Immunology 15 (2): 171\u201381. https:\/\/doi.org\/10.1038\/cmi.2016.60.","journal-title":"Cellular & Molecular Immunology"},{"issue":"7","key":"2533_CR220","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/aps.2012.39","volume":"33","author":"Yping Zhang","year":"2012","unstructured":"Zhang, Yping, Wbin Li, Wli Wang, J. Liu, Sxia Song, Llin Bai, et al. 2012. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats. Acta Pharmacologica Sinica 33 (7): 897\u2013908. https:\/\/doi.org\/10.1038\/aps.2012.39.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"7","key":"2533_CR221","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ajpath.2021.04.003","volume":"191","author":"C Jiang","year":"2021","unstructured":"Jiang, C., G. Liu, L. Cai, J. Deshane, V. Antony, V.J. Thannickal, et al. 2021. Divergent regulation of alveolar type 2 cell and fibroblast apoptosis by Plasminogen Activator Inhibitor 1 in lung fibrosis. The American Journal of Pathology 191 (7): 1227\u201339. https:\/\/doi.org\/10.1016\/j.ajpath.2021.04.003.","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"2533_CR222","doi-asserted-by":"publisher","first-page":"L463","DOI":"10.1152\/ajplung.00099.2011","volume":"302","author":"YP Bhandary","year":"2012","unstructured":"Bhandary, Y.P., S.K. Shetty, A.S. Marudamuthu, M.R. Gyetko, S. Idell, M. Gharaee-Kermani, et al. 2012. Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic system. American Journal of Physiology-Lung Cellular and Molecular Physiology 302 (5): L463-73. https:\/\/doi.org\/10.1152\/ajplung.00099.2011.","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"15","key":"2533_CR223","doi-asserted-by":"publisher","DOI":"10.3390\/cells12152008","volume":"12","author":"T Rana","year":"2023","unstructured":"Rana, T., C. Jiang, S. Banerjee, N. Yi, J.W. Zmijewski, G. Liu, et al. 2023. PAI-1 regulation of p53 expression and senescence in type II alveolar epithelial cells. Cells 12 (15): 2008. https:\/\/doi.org\/10.3390\/cells12152008.","journal-title":"Cells"},{"issue":"24","key":"2533_CR224","doi-asserted-by":"publisher","first-page":"21843","DOI":"10.1074\/jbc.M109745200","volume":"277","author":"Y Ogawara","year":"2002","unstructured":"Ogawara, Y., S. Kishishita, T. Obata, Y. Isazawa, T. Suzuki, K. Tanaka, et al. 2002. Akt enhances Mdm2-mediated ubiquitination and degradation of p53. Journal of Biological Chemistry 277 (24): 21843\u201350. https:\/\/doi.org\/10.1074\/jbc.M109745200.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"2533_CR225","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.thromres.2012.09.003","volume":"131","author":"YP Zhang","year":"2013","unstructured":"Zhang, Y.P., W.L. Wang, J. Liu, W.B. Li, L.L. Bai, Y.D. Yuan, et al. 2013. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca2\u2009+\u2009signaling. Thrombosis Research 131 (1): 64\u201371. https:\/\/doi.org\/10.1016\/j.thromres.2012.09.003.","journal-title":"Thrombosis Research"},{"issue":"5","key":"2533_CR226","doi-asserted-by":"publisher","first-page":"G657","DOI":"10.1152\/ajpgi.00107.2009","volume":"298","author":"C Von Montfort","year":"2010","unstructured":"Von Montfort, C., J.I. Beier, J.P. Kaiser, L. Guo, S. Joshi-Barve, M.T. Pritchard, et al. 2010. PAI-1 plays a protective role in CCl4 -induced hepatic fibrosis in mice: Role of hepatocyte division. American Journal of Physiology-Gastrointestinal and Liver Physiology 298 (5): G657-66. https:\/\/doi.org\/10.1152\/ajpgi.00107.2009.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"issue":"5","key":"2533_CR227","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3390\/ijms22052721","volume":"22","author":"M Sillen","year":"2021","unstructured":"Sillen, M., and P. J. Declerck. 2021. A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target? IJMS 22(5):2721. https:\/\/doi.org\/10.3390\/ijms22052721","journal-title":"IJMS"},{"key":"2533_CR228","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365894","volume":"15","author":"AA Ibrahim","year":"2024","unstructured":"Ibrahim, A.A., T. Fujimura, T. Uno, T. Terada, Kichi Hirano, H. Hosokawa, et al. 2024. Plasminogen activator inhibitor-1 promotes immune evasion in tumors by facilitating the expression of programmed cell death-ligand 1. Frontiers in Immunology 15: 1365894. https:\/\/doi.org\/10.3389\/fimmu.2024.1365894.","journal-title":"Frontiers in Immunology"},{"issue":"15","key":"2533_CR229","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","volume":"75","author":"VR Placencio","year":"2015","unstructured":"Placencio, V.R., and Y.A. DeClerck. 2015. Plasminogen Activator Inhibitor-1 in cancer: Rationale and insight for future therapeutic testing. Cancer Research 75 (15): 2969\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0876.","journal-title":"Cancer Research"},{"issue":"9","key":"2533_CR230","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/biom15091317","volume":"15","author":"T Fujimura","year":"2025","unstructured":"Fujimura, T., Y. Muto, and Y. Asano. 2025. Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition. Biomolecules 15(9):1317. https:\/\/doi.org\/10.3390\/biom15091317","journal-title":"Biomolecules"},{"issue":"8","key":"2533_CR231","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1167\/iovs.19-27306","volume":"60","author":"K Sugioka","year":"2019","unstructured":"Sugioka, K., K. Yoshida, J. Murakami, M. Itahashi, H. Mishima, T. Nishida, et al. 2019. Inhibition by Epigallocatechin Gallate of IL-1-induced Urokinase-Type Plasminogen Activator expression and collagen degradation by corneal fibroblasts. Investigative Ophthalmology & Visual Science 60 (8): 2895\u2013903. https:\/\/doi.org\/10.1167\/iovs.19-27306.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"2533_CR232","first-page":"997","volume":"27","author":"T Nonaka","year":"2000","unstructured":"Nonaka, T., H. Kikuchi, T. Ikeda, Y. Okamoto, C. Hamanishi, and S. Tanaka. 2000. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of Osteoarthritis and Rheumatoid Arthritis. The Journal of Rheumatology 27 (4): 997\u20131004.","journal-title":"The Journal of Rheumatology"},{"issue":"43","key":"2533_CR233","doi-asserted-by":"publisher","first-page":"40215","DOI":"10.1074\/jbc.M101647200","volume":"276","author":"AT Ho","year":"2001","unstructured":"Ho, A. T., E. B. Voura, P. D. Soloway, K. L. M. Watson, and R. Khokha. 2001. MMP Inhibitors Augment Fibroblast Adhesion through Stabilization of Focal Adhesion Contacts and Up-regulation of Cadherin Function. Journal of Biological Chemistry 276(43):40215\u201340224. https:\/\/doi.org\/10.1074\/jbc.M101647200","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"2533_CR234","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1023\/A:1013908332232","volume":"67","author":"HR Lijnen","year":"2002","unstructured":"Lijnen, H. R. 2002. Matrix Metalloproteinases and Cellular Fibrinolytic Activity. Biochemistry (Moscow) 67(1):92\u201398. https:\/\/doi.org\/10.1023\/A:1013908332232","journal-title":"Biochemistry (Moscow)"},{"issue":"1","key":"2533_CR235","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1165\/rcmb.2011-0139OC","volume":"46","author":"WT Huang","year":"2012","unstructured":"Huang, W. T., P. K. Vayalil, T. Miyata, J. Hagood, and R. M. Liu. 2012. Therapeutic Value of Small Molecule Inhibitor to Plasminogen Activator Inhibitor\u20131 for Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology 46(1):87\u201395. https:\/\/doi.org\/10.1165\/rcmb.2011-0139OC","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"4","key":"2533_CR236","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3892\/mmr.2020.11360","volume":"22","author":"R Noguchi","year":"2020","unstructured":"Noguchi, R., K. Kaji, T. Namisaki, K. Moriya, H. Kawaratani, M. Kitade, et al. 2020. Novel oral Plasminogen Activator Inhibitor\u20111 inhibitor TM5275 attenuates hepatic fibrosis under Metabolic Syndrome via suppression of activated hepatic stellate cells in rats. Molecular Medicine Reports 22 (4): 2948\u201356. https:\/\/doi.org\/10.3892\/mmr.2020.11360.","journal-title":"Molecular Medicine Reports"},{"issue":"21","key":"2533_CR237","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008951","volume":"137","author":"CB Keragala","year":"2021","unstructured":"Keragala, C. B., and R. L. Medcalf. 2021. Plasminogen: an enigmatic zymogen. Blood 137(21):2881\u20132889. https:\/\/doi.org\/10.1182\/blood.2020008951","journal-title":"Blood"},{"issue":"2","key":"2533_CR238","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1358\/dnp.2008.21.2.1188197","volume":"21","author":"The Urokinase Plasminogen Activator System in Cancer","year":"2008","unstructured":"The Urokinase Plasminogen Activator System in Cancer. 2008. A Putative Therapeutic Target. Drug News & Perspectives 21(2):107. https:\/\/doi.org\/10.1358\/dnp.2008.21.2.1188197","journal-title":"Drug News & Perspectives"},{"issue":"3","key":"2533_CR239","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.coph.2013.05.014","volume":"13","author":"M Schuliga","year":"2013","unstructured":"Schuliga, M., G. Westall, Y. Xia, and A.G. Stewart. 2013. The plasminogen activation system: New targets in lung inflammation and remodeling. Current Opinion in Pharmacology 13 (3): 386\u201393. https:\/\/doi.org\/10.1016\/j.coph.2013.05.014.","journal-title":"Current Opinion in Pharmacology"},{"key":"2533_CR240","doi-asserted-by":"publisher","unstructured":"Kwaan, H. C., B. McMahon. The Role of plasminogen-plasmin system in cancer. In: Kwaan HC, Green D,Coagulation in Cancer [Internet]., M. A. Boston, and U. S. Springer. 2009. [cited 2026 Apr 25]. pp. 43\u201366. (Cancer Treatment and Research). Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/978-0-387-79962-9_4 doi:10.1007\/978-0-387-79962-9_4.","DOI":"10.1007\/978-0-387-79962-9_4"},{"issue":"4","key":"2533_CR241","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1517\/14712598.1.4.683","volume":"1","author":"M Schmitt","year":"2001","unstructured":"Schmitt, M., V. Magdolen, S. Sperl, B. Muehlenweg, and N. Harbeck. 2001. Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours. Expert Opinion on Biological Therapy 1(4):683\u2013691. https:\/\/doi.org\/10.1517\/14712598.1.4.683","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"2\u20133","key":"2533_CR242","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1054\/fipr.2000.0079","volume":"14","author":"M Schmitt","year":"2000","unstructured":"Schmitt, M., O.G. Wilhelm, U. Reuning, A. Kr\u00fcger, N. Harbeck, E. Lengyel, et al. 2000. The urokinase plasminogen activator system as a novel target for tumour therapy. Fibrinolysis and Proteolysis 14 (2\u20133): 114\u201332. https:\/\/doi.org\/10.1054\/fipr.2000.0079.","journal-title":"Fibrinolysis and Proteolysis"},{"issue":"3","key":"2533_CR243","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030498","volume":"14","author":"MT Masucci","year":"2022","unstructured":"Masucci, M.T., M. Minopoli, G. Di Carluccio, M.L. Motti, and M.V. Carriero. 2022. Therapeutic strategies targeting urokinase and its receptor in cancer. Cancers 14 (3): 498. https:\/\/doi.org\/10.3390\/cancers14030498.","journal-title":"Cancers"},{"key":"2533_CR244","doi-asserted-by":"publisher","unstructured":"Sisson, T. H., S. Fortier, L. C. Tsoi, R. Alonzo, N. Subbotina, and M. Warnock et al. Targeting plasminogen activator inhibitor-1 with a novel small molecule inhibitor attenuates lung fibrosis [Internet]. In Review; 2025 [cited 2026 Apr 25]. Available from: https:\/\/www.researchsquare.com\/article\/rs-6951289\/v1https:\/\/doi.org\/10.21203\/rs.3.rs-6951289\/v1","DOI":"10.21203\/rs.3.rs-6951289\/v1"},{"issue":"1","key":"2533_CR245","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05847-8","volume":"22","author":"Y Li","year":"2024","unstructured":"Li, Y., L. Liu, and B. Li. 2024. Role of ENO1 and its targeted therapy in tumors. Journal of Translational Medicine 22 (1): 1025. https:\/\/doi.org\/10.1186\/s12967-024-05847-8.","journal-title":"Journal of Translational Medicine"},{"issue":"8","key":"2533_CR246","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.jtha.2024.04.006","volume":"22","author":"F Ferraresso","year":"2024","unstructured":"Ferraresso, F., J. Leung, and C. J. Kastrup. 2024. RNA therapeutics to control fibrinolysis: review on applications in biology and medicine. Journal of Thrombosis and Haemostasis 22(8):2103\u20132114. https:\/\/doi.org\/10.1016\/j.jtha.2024.04.006","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"2533_CR247","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jth.12064","volume":"11","author":"A Godier","year":"2013","unstructured":"Godier, A., and B. J. Hunt. 2013. Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease. Journal of Thrombosis and Haemostasis 11(1):26\u201334. https:\/\/doi.org\/10.1111\/jth.12064","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"2533_CR248","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115504","volume":"165","author":"M Liu","year":"2025","unstructured":"Liu, M., G. Wang, J. Gao, M. Peng, H. Feng, X. Liang, et al. 2025. Targeting annexin A2 enhances anti-PD-1 immunotherapy in pancreatic ductal adenocarcinoma by remodeling the tumor immune microenvironment. International Immunopharmacology 165: 115504. https:\/\/doi.org\/10.1016\/j.intimp.2025.115504.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"2533_CR249","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02160-9","volume":"12","author":"X Shu","year":"2021","unstructured":"Shu, X., K.Y. Cao, H.Q. Liu, L. Yu, L.X. Sun, Z.H. Yang, et al. 2021. Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK\/mTOR pathway. Stem Cell Research & Therapy 12 (1): 119. https:\/\/doi.org\/10.1186\/s13287-021-02160-9.","journal-title":"Stem Cell Research & Therapy"},{"issue":"17","key":"2533_CR250","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713618","volume":"24","author":"HY Choi","year":"2023","unstructured":"Choi, H.Y., and J.E. Chang. 2023. Targeted therapy for cancers: From ongoing clinical trials to FDA-approved drugs. International Journal of Molecular Sciences 24 (17): 13618. https:\/\/doi.org\/10.3390\/ijms241713618.","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"2533_CR251","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2967\/jnumed.121.263177","volume":"63","author":"EA Carlsen","year":"2022","unstructured":"Carlsen, E.A., M. Loft, A. Loft, A.K. Berthelsen, S.W. Langer, U. Knigge, et al. 2022. Prospective Phase II trial of prognostication by68 Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR-targeted therapy. Journal of Nuclear Medicine 63 (9): 1371\u20137. https:\/\/doi.org\/10.2967\/jnumed.121.263177.","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"2533_CR252","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16050596","volume":"16","author":"ML Lin","year":"2024","unstructured":"Lin, M.L., S.Y. Wu, J.P. Chen, Y.C. Lu, S.M. Jung, S.P. Wey, et al. 2024. Targeted thrombolysis with magnetic nanotherapeutics: A translational assessment. Pharmaceutics 16 (5): 596. https:\/\/doi.org\/10.3390\/pharmaceutics16050596.","journal-title":"Pharmaceutics"},{"issue":"12","key":"2533_CR253","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1182\/blood-2017-09-806729","volume":"131","author":"AD Shapiro","year":"2018","unstructured":"Shapiro, A.D., C. Nakar, J.M. Parker, G.R. Albert, J.E. Moran, K. Thibaudeau, et al. 2018. Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency. Blood 131 (12): 1301\u201310. https:\/\/doi.org\/10.1182\/blood-2017-09-806729.","journal-title":"Blood"},{"issue":"1","key":"2533_CR254","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50445-1","volume":"14","author":"T Hirai","year":"2024","unstructured":"Hirai, T., K. Asano, I. Ito, Y. Miyazaki, H. Sugiura, M. Agirbasli, et al. 2024. A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19. Scientific Reports 14 (1): 165. https:\/\/doi.org\/10.1038\/s41598-023-50445-1.","journal-title":"Scientific Reports"},{"key":"2533_CR255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2025.03.019","volume":"287","author":"L Cho","year":"2025","unstructured":"Cho, L., S.J. Nicholls, B.G. Nordestgaard, U. Landmesser, S. Tsimikas, M.J. Blaha, et al. 2025. Design and rationale of Lp(a)HORIZON trial: Assessing the effect of Lipoprotein(a) lowering with Pelacarsen on major cardiovascular events in patients with CVD and elevated Lp(a). American Heart Journal 287: 1\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2025.03.019.","journal-title":"American Heart Journal"},{"issue":"12","key":"2533_CR256","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1160\/TH08-07-0427","volume":"100","author":"RD Balsara","year":"2008","unstructured":"Balsara, R. D., and V. A. Ploplis. 2008. Plasminogen activator inhibitor-1: The double-edged sword in apoptosis. Thrombosis And Haemostasis 100(12):1029\u20131036. https:\/\/doi.org\/10.1160\/TH08-07-0427","journal-title":"Thrombosis And Haemostasis"},{"issue":"3","key":"2533_CR257","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10555-019-09806-4","volume":"38","author":"MH Kubala","year":"2019","unstructured":"Kubala, M.H., and Y.A. DeClerck. 2019. The plasminogen activator inhibitor-1 paradox in cancer: A mechanistic understanding. Cancer Metastasis Reviews 38 (3): 483\u201392. https:\/\/doi.org\/10.1007\/s10555-019-09806-4.","journal-title":"Cancer Metastasis Reviews"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02533-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02533-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:13:15Z","timestamp":1785517995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02533-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":257,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2533"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02533-3","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"169"}}